Podcasts about population health sciences

Today we are continuing our discussion on gene therapy, with Dr Rajvinder Karda, hosted by Olivia. Raj is both a researcher and professor at the UCL Institute for Women's Health, with her role as an associate professor of Gene Therapy, as well as leading a team of research focussing on developing pre-clinical gene therapy and RNA editing treatments for childhood epilepsy, including Dravet Syndrome. Listen in to learn more about Raj's work in the field of gene therapy, as she explains more about how gene therapies are being researched and developed for pre-clinical trials, including in her lab where her team is working on the development of gene therapies for treating Dravet Syndrome. Date of episode recording: 2025-01-22T00:00:00Z Duration: 00:30:16 Language of episode: English Presenter:Olivia Moir Guests: Dr Rajvinder Karda Producer: Olivia, UCL Institute for Women's Health, UCL Faculty of Population Health Sciences

On this episode of Managed Care Cast, we're talking with Allison Ju-Chen Hu, PhD, a postdoctoral associate in the Department of Population Health Sciences at Weill Cornell Medicine. Her study, "Medicaid Managed Care Network Adequacy Standards and Mental Health Care Access," examined the association between quantitative network adequacy standards (NAS) and mental health care access among adult Medicaid enrollees, including those with mental health conditions.

Dr. Jason Paltzer is the Executive Director of The Meros Center and visiting professor at Wisconsin Lutheran College. Meros is a research and training community serving organizations with measuring and growing Christian health ministry. He has 20 years of experience working alongside global faith-based organizations and local churches to develop, implement, and study community strategies that integrate spiritual and physical health. His research interests include global substance abuse and church/community-based strategies for recovery and prevention. He has a passion for connecting faith, public health, and missions to help others live as designed by God. His MPH is from the University of Minnesota and PhD in Population Health Sciences from the University of Wisconsin.

Dr. Toyosi Onwuemene is an Associate Professor of Medicine and an Associate Professor in Population Health Sciences, dedicated to both advancing healthcare and improving the well-being of her patients. Despite her success as a physician and educator, she found herself overwhelmed by the demands of her profession, leading her to seek out new ways to manage her career and finances.In this episode, join host Dr. Latifat and her guest as they talk about the power of investing in yourself, how financial confidence can transform your life, and the importance of community support.Key Takeaways:Investing in yourself opens new doors.Financial confidence brings time and freedom.Community support elevates growth.Timestamps:00:00 – Introduction to Dr. Toyosi and her journey.03:15 – How Dr. Toyosi began prioritizing her financial education.05:30 – The power of shifting your mindset around money.10:00 – Building confidence through the Money School.12:45 – The impact of financial freedom on professional life.17:00 – Dr. Toyosi's decision to stop taking call and reclaim her time.22:30 – The importance of making intentional, bold moves in life.27:00 – Family benefits from improved financial mindset and time freedom.32:00 – How new investments and opportunities transformed her life.39:00 – The value of surrounding yourself with a supportive community. Click Here to Secure Your Spot for the 2025 Wealthy You In-Person Gathering.It's time to finally take action on your financial goals. Join other women physicians who are choosing an uncommon life of financial and life freedom by registering for the 3-DAY Money Moves Challenge for women physicians. Register HereReady to explore the transformative power of sabbaticals?Download the free Sabbatical Guide at Moneyfitmd.com/Sabbatical and embark on a journey to financial freedom and personal growth. Share the link with your fellow physicians and join the movement to normalize taking pauses for a healthier and more fulfilling life.If you are a Hardworking, Busy Woman physician who wants to get good at money without wasting more time sifting through the internet. This is for you. https://www.moneyfitmd.com/guideWe are social:Facebook: https://web.facebook.com/MoneyfitMD/Instagram: https://www.instagram.com/moneyfitmd/Youtube: youtube.com/@money...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sarah Shizuko Morimoto, PsyD Digital therapeutics are a rapidly developing type of treatment option across several therapeutic areas, including mental health. And while the technology is advancing rapidly, the science behind it needs time to catch up, so it's important to evaluate the supporting evidence when considering digital therapeutics for mental health.1 Joining Dr. Charles Turck to share her insights on how we can assess digital therapeutics is Dr. Sarah Shizuko Morimoto, Associate Professor of Population Health Sciences at the University of Utah in Salt Lake City. Reference: American Psychiatric Association. Accessed July 3, 2024. https://www.psychiatry.org/psychiatrists/practice/mental-health-apps/the-app-evaluation-model Dr. Morimoto is a paid consultant of Otsuka. November 2024 US.UNB.X.24.00100

In the 5 Second Rule podcast by APIC, hosts Lerenza Howard and Kelly Holmes discuss infection prevention and control in the context of hurricanes with professionals, Lori Crow and Cindy Prins. From sharing personal experiences to breaking down the role of infection preventionists in such situations, the podcast covers a wide range of topics - from maintaining food safety during power outages to averting mold growth post-flooding. Listen to the IPC experts shed insights on the crucial role played by IPs and infection prevention measures during a hurricane. Hosted by: Lerenza Howard, MHA, CIC, LSSGB and Kelly Holmes, MS, CIC, FAPIC About our Guests: Cindy Prins, PhD, MPH, CIC, CPH, FSHEA Dr. Cindy Prins is an Associate Professor in the Department of Population Health Sciences, College of Medicine at the University of Central Florida, and is part of the UCF Infectious Disease and Travel Health Initiative. She is an infectious disease epidemiologist whose research focuses on infection prevention and control in both healthcare and non-healthcare settings, and on compliance with vaccine recommendations. Dr. Prins is Board Certified in Infection Control (CIC) and Public Health (CPH) and is a Fellow of the Society for Healthcare Epidemiology of America (FSHEA). Lori Zeringue Crow, MPH, MS, CPH Lori holds a background in both microbiology and public health. After a career as a college microbiology instructor, Lori pivoted her path into public health by going back to school to obtain her MPH. Lori now works in public health emergency preparedness and response at a state health department. In that capacity, Lori is trained to prepare for and respond to all types of hazards that can impact public health. Two of the most common types of hazards her department encounters are hurricanes and flooding. Lori's experience with the devastation that hurricanes can bring is not only professional, but also personal as she has lived most of her life on the Gulf Coast. Lori believes infection prevention plays a role in minimizing the impact hurricanes can have on people. She combines her microbiology and public health background to advocate for the inclusion of infection control in hurricane preparedness and response Further Resources: How to build an emergency kit by Ready.gov General public health messaging before, during, and after hurricanes and floods. Covers food safety, mold, proper care of wounds, safe water, waterborne diseases: CDC Preparedness and Safety Messaging for Hurricanes, Flooding, and Similar Disasters CDC's Safe and Healthy Diapering for Emergency Settings and Shelters fact sheet CDC's Preventing Diarrheal Illness After a Disaster fact sheet  APIC's Infection Prevention and Control for Shelters during Disasters Creating a food safety plan for hurricane season: Foodsafety.gov  2023 APIC Emerging Infectious Diseases Task Force: Infection Prevention and Control for Shelters During Disasters Emergency Water Supply Planning Guide for Hospitals and Healthcare Facilities, 2019

To mark Hispanic Heritage Month, in this episode, six cancer experts discuss Latino representation in clinical trials, translational research, and healthcare professions. Hispanic and Latino people comprise nearly 20% of the U.S. population, but less than 6% of physicians nationwide identify as Hispanic. “The pipeline issue continues to be a huge issue for us,” said Amelie Ramirez, of UT Health San Antonio and Mays Cancer Center. “As our population continues to grow, in terms of the Latino population, we definitely need more [Latino physicians].” Since trust plays a huge role in recruiting participants, the dearth of Latinos in health care affects clinical trials and translational research, said Cruz-Correa, of the University of Puerto Rico and PanOncology Trials. “For our patients, for our communities, language is still important—that concordance between the physician that is telling you about the study and the patient's background.” Still, it's important to remember that Latinos are a very diverse group, who speak languages other than Spanish, said Carvajal-Carmona, of UC Davis. Latino people of the myriad ethnicities throughout the Americas have a variety of histories, cultures, and cancer risk factors, he said. And for Latino professionals in oncology, it's vital to continue making their presence known, said Edith Perez, of Mayo Clinic. “We are part of the population. We are part of the intellectual minds that exist in this nation. And we're here to help lead and collaborate.” Panelists included: Moderator: Ruben Mesa, president, Atrium Health Levine Cancer; executive director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center Luis Carvajal-Carmona, professor, Auburn Community Cancer Endowed Chair in Basic Science, associate vice chancellor for the Office of Academic Diversity, University of California, Davis Marcia Cruz-Correa, lead investigator and director, Clinical & Translational Research, University of Puerto Rico Comprehensive Cancer Center; chief medical officer, PanOncology Trials; professor of medicine and biochemistry, University of Puerto Rico School of Medicine Edith Perez, professor emeritus, Mayo Clinic Amelie Ramirez, professor, director of the Institute for Health Promotion Research, and chair of the Department of Population Health Sciences, UT Health San Antonio; associate director of cancer outreach and engagement, Mays Cancer Center Yolanda Sanchez, director and CEO, University of New Mexico Comprehensive Cancer Center A transcript of this conversation is available on the ⁠Cancer History Project⁠.

We are back here today to talk about menopause. We are going to be diving into the basics on what it is and what to expect, and then some ideas on how to optimize lifestyle in this stage as well as various, sometimes conflicting views, on treatment and management options for individuals going through menopause. Joining me in this is episode is none other than a certified British Menopause Society ‘Menopause specialist', Mr Vikram Talaulikar, who is coming to us with a strong clinical background, as an associate specialist at the reproductive medicine unit at UCLH, and an honorary associate professor here at UCL. To learn more about Vikram's work visit his profile on UCHL (https://www.uclh.nhs.uk/our-services/find-consultant/mr-vikram-talaulikar) and his LinkedIn (https://www.linkedin.com/in/vikram-sinai-talaulikar-13565411/) Date of episode recording: 2024-09-26T00:00:00Z Duration: 00:22:41 Language of episode: English Presenter: Olivia Moir Guests: Mr Vikram Talaulikar Producer: Olivia, UCL Faculty of Population Health Sciences

We are back here today to talk about menopause. We are going to be diving into the basics on what it is and what to expect, and then some ideas on how to optimize lifestyle in this stage as well as various, sometimes conflicting views, on treatment and management options for individuals going through menopause. Joining me in this is episode is none other than a certified British Menopause Society ‘Menopause specialist', Mr Vikram Talaulikar, who is coming to us with a strong clinical background, as an associate specialist at the reproductive medicine unit at UCLH, and an honorary associate professor here at UCL. To learn more about Vikram's work visit his profile on UCHL (https://www.uclh.nhs.uk/our-services/find-consultant/mr-vikram-talaulikar) and his LinkedIn (https://www.linkedin.com/in/vikram-sinai-talaulikar-13565411/) Date of episode recording: 2024-09-26T00:00:00Z Duration: 00:22:41 Language of episode: English Presenter: Olivia Moir Guests: Mr Vikram Talaulikar  Producer: Olivia, UCL Faculty of Population Health Sciences 

To learn more about this important field of cardiovascular clinical research, I invited Dr. Gregg Stone on the podcast. Dr. Stone is an Interventional Cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY.  He has served as the national or international principal investigator for more than 150 national and international multicenter randomized trials and studies (many of which have led to new device approval or indications in the US), has authored more than 3000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world.  With an H-index of 202, Dr. Stone has been recognized in Nature Medicine as one of the most prolific authors in science, and by the Web of Science as among the top 0.01% of cited researchers in science.  Dr. Stone completed medical school at Johns Hopkins University Medical Center, in Baltimore, MD, and his internship and residency at the New York Hospital-Cornell Medical Center in New York City.  He completed his general cardiology fellowship at Cedars-Sinai Medical Center in Los Angeles, CA and subsequently a dedicated fellowship in advanced coronary angioplasty in Kansas City, MO.  Please join me in welcoming Dr. Gregg Stone on the Clinical Trial Podcast. Sponsor(s): This podcast is brought to you by Florence Healthcare. Florence eliminates chaotic workflows in clinical research operations with remote access and digital workflow platforms. More than 12,000 study sites, sponsors, and CROs in 45 countries trust them to accelerate their operations. To learn more, visit https://florencehc.com This podcast is brought to you by Slope. Slope drives operational excellence for highly complex, sample-intensive, early-phase clinical trials. The platform transforms chaotic clinical trial supply chains into protocol-specific operational workflows for sponsors, CROs, clinical research sites and labs. Learn more at slopeclinical.com

On this week's show: Companion animals such as dogs occupy the same environment we do, which can make them good sentinels for human health, and DNA gives clues to ancient Maya rituals and malaria's global spread Contributing Correspondent Andrew Curry joins host Sarah Crespi to discuss two very different studies that used DNA to dig into our past. One study reveals details of child sacrifices in an ancient Maya city. The other story is on the surprising historical reach of malaria, from Belgium to the Himalayas to South America.   Next on the show, using our canine companions to track human health. Courtney Sexton, a postdoctoral research fellow in the Department of Population Health Sciences at the Virginia-Maryland College of Veterinary Medicine, talks about what we can learn from these furry friends that tend to be exposed to many of the same things we are such as pesticides and cleaning chemicals.   Finally, in a sponsored segment from the Science/AAAS Custom Publishing Office, Jackie Oberst, associate editor of custom publishing, interviews professors Miriam Merad and Brian Brown about the evolution of immunology in health care. This segment is sponsored by the Icahn School of Medicine at Mount Sinai.   This week's episode was produced with help from Podigy.   About the Science Podcast   Authors: Sarah Crespi; Andrew Curry   Episode page: https://www.science.org/doi/10.1126/science.zxgwbqo Learn more about your ad choices. Visit megaphone.fm/adchoices

On this week's show: Companion animals such as dogs occupy the same environment we do, which can make them good sentinels for human health, and DNA gives clues to ancient Maya rituals and malaria's global spread Contributing Correspondent Andrew Curry joins host Sarah Crespi to discuss two very different studies that used DNA to dig into our past. One study reveals details of child sacrifices in an ancient Maya city. The other story is on the surprising historical reach of malaria, from Belgium to the Himalayas to South America.   Next on the show, using our canine companions to track human health. Courtney Sexton, a postdoctoral research fellow in the Department of Population Health Sciences at the Virginia-Maryland College of Veterinary Medicine, talks about what we can learn from these furry friends that tend to be exposed to many of the same things we are such as pesticides and cleaning chemicals.   Finally, in a sponsored segment from the Science/AAAS Custom Publishing Office, Jackie Oberst, associate editor of custom publishing, interviews professors Miriam Merad and Brian Brown about the evolution of immunology in health care. This segment is sponsored by the Icahn School of Medicine at Mount Sinai.   This week's episode was produced with help from Podigy.   About the Science Podcast   Authors: Sarah Crespi; Andrew Curry   Episode page: https://www.science.org/doi/10.1126/science.zxgwbqo Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, we will hear from Dr. Sharan Rai and Dr. Shilpa Bhupathiraju, co-authors of the article “A South Asian Mediterranean-style diet is associated with favorable adiposity measures and lower diabetes risk.” In this episode, we will discuss exactly what this diet is and how it can prevent and treat diet-related chronic conditions. We also discuss the role of cultural foods, something fundamental to Yumlish's mission, how these foods and the surrounding community can illuminate our normalized understanding of diet, and how the knowledge could help assist in the journey to a sustainable, healthy lifestyle.  Dr. Bhupathiraju is an Assistant Professor in Medicine and Nutrition at Harvard Medical School and Harvard T.H. Chan School of Public Health and an Associate Epidemiologist at Brigham and Women's Hospital, Boston. Her research focuses on dietary and lifestyle predictors of cardiometabolic disease. Dr Sharan Rai is a postdoctoral fellow at Massachusetts General Hospital. She recently completed her PhD in Population Health Sciences at the Harvard T.H. Chan School of Public Health. Her research focused on dietary and lifestyle predictors of gout and other cardiometabolic diseases.   “What I do want to say is that while holding on to your culture, I think there is a space for promoting good nutrition, going back to your roots, and remembering that with minimally processed foods It can be healthier.” - Dr. Bhupathiraju On this Episode, you will Learn:  Dr. Rai and Dr.  Bhupathiraju's journies into the nutrition field The specifics of a South Asian Mediterranean-style diet  The results of their study and its applications Nutrition through a South Asian lens The role of community and family gatherings on culturally relevant nutrition Connect with Yumlish! Website Instagram Twitter Facebook LinkedIn YouTube  Connect with Dr. Rai and Dr. Bhupathiraju! Website  Dr. Bhupathiraju's LinkedIn Dr. Rai's LinkedIn Twitter --- Send in a voice message: https://podcasters.spotify.com/pod/show/yumlish/message

Fei Wang, Professor of Population Health Sciences and Emergency Medicine at the Weill Cornell Medical College and Founding Director of the WCM Institute of AI for Digital Health (AIDH) speaks with Pitt HexAI guest host Brent Phillips about Dr. Wang's work at Cornell and about Cornell's new Institute of AI for Digital Health. Dr. Wang and Brent also discuss new and existing data sources for health AI research, the evolution and power of complex machine learning models and their impact on informatics and computational health fields, education in the AI age and about explainable AI and advice for private sector companies interested in collaborating with academic institutions. 

Maintenance therapy for patients with acute myeloid leukemia, particularly those who are ineligible for transplant, can be critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Thomas LeBlanc, MD, hematologic oncologist, associate professor of Medicine, and associate professor in Population Health Sciences at Duke Cancer Institute, about the importance of keeping patients with acute myeloid leukemia in first remission as long as possible through maintenance therapy.   “You have to be aware of the benefits of maintenance therapy…and for patients who are being considered for transplant but who do not end up getting a transplant, it should really be the default option that those patients receive a maintenance therapy.” –Thomas W. LeBlanc, MD   Guest:         Thomas W. LeBlanc, MD Hematologic Oncologist, Associate Professor of Medicine, Associate Professor in Population Health Sciences Duke Cancer Network, Duke Cancer Institute Durham, North Carolina   This is the fourth and final episode of a four-part series developed in connection with the ACCC education program Achieving and Maintaining Better Outcomes for Patients with Acute Myeloid Leukemia. This episode was made possible with support by Bristol Myers-Squibb.   Additional Reading/Sources Improving Care Delivery for Transplant-Ineligible Patients with AML AML Care Coordination in the Community Setting [Video Podcast] Critical Conversation Strategies for Patients with AML [Video Podcast] Strategies to Addressing Disparities in Patients with AML [Video Podcast] Shared Decision-making in Acute Myeloid Leukemia Achieving and Maintaining Better Outcomes for Patients with AML Talking about Acute Myeloid Leukemia (Cancer Support Community) Shared Decision-making: Practical Implementation for the Oncology Team (ACCC)

Professor Ibrahim Abubakar, FMedSci is Pro-Provost (Health), Dean, Faculty of Population Health Sciences and Professor of Infectious Disease Epidemiology, University College London ( UCL - https://www.ucl.ac.uk/tb/people/professor-ibrahim-abubakar ). He was previously director of the UCL Institute for Global Health until July 2021. Prof. Abubakar was appointed National Institute for Health and Care Research (NIHR) Senior Investigator in 2017 and elected Fellow Academy of Medical Sciences in 2020. He led the UCL Centre for Infectious Disease Epidemiology, UCL-TB and was a senior investigator at the Medical Research Council (MRC) Clinical Trials Unit. He was also head of TB at Public Health England and prior to his appointment at UCL, he was Professor in Health Protection at the Norwich Medical School. Prof. Abubakar qualified in medicine in 1992 and initially trained in general medicine before specializing in public health medicine. His academic public health training was undertaken at London School of Hygiene & Tropical Medicine (LSHTM), University of Cambridge and the University of East Anglia. Prof. Abubakar is a member of the Global Preparedness Monitoring Board ( https://www.gpmb.org/ ), Chair of Lancet Migration: global collaboration to advance migration health, Lancet Nigeria Commission and the NIHR Global Health Professorship Committee. He also served as chair of the WHO Strategic and Technical Advisory Group for Tuberculosis until 2019 and of the Wellcome Trust Expert Review Group on Population Health until 2022. Support the show

“No study had been funded to really look at the needs of our Latino cancer survivors. We're the first study to be doing this," said Dr. Amelie Ramirez, chair of Population Health Sciences at UT Health San Antonio. "And they are so grateful to us because they said, 'nobody's bothered to ask me about my cancer journey.'”

News: The NYC Deliverista minimum wage, and how it may reduce bicyclist fatalities. 2:13 The irony of drivers waiting patiently at Christmas Light Displays, with Associate Director of Data Core at Stanford Center for Population Health Sciences, Bella Chu. 8:40 The irony of drivers waiting patiently at In-n-Out, with Peter Flax, journalist and former Editor in Chief of Bicycling Magazine. 19:59 The irony of the High Cost of Free Parking with its author, Distinguished Research Professor in the Department of Urban Planning at UCLA, Donald Shoup. With Don Ward (rebroadcast portion). 38:17

Makella S. Coudray, PHD, MPH Epidemiologist National Minority Quality Forum Dr. Makella S. Coudray is an infectious disease epidemiologist with the National Minority Quality Forum and a Postdoctoral Scholar in the Department of Population Health Sciences at the University of Central Florida. She holds a Doctor of Philosophy (PhD, 2020) in Public Health with a concentration in Epidemiology from Florida International University, a Master of Public Health (MPH, 2016) in Epidemiology and a Bachelor of Science (BSc, 2015) in Biology from St. George's University (Grenada). Dr. Coudray hails from the beautiful twin island republic of Trinidad and Tobago and has strong ties to Guyana (maternal heritage). Currently, Dr. Coudray's work investigates sexual health disparities among marginalized populations- especially transgender women, and cisgender women of color- using a bio-behavioral lens. Specifically, she uses quantitative methods to examine the social determinants of sexual health risk factors. Additionally, her work also explores the impact of social and structural determinants of health on COVID-19 outcomes. In her role at NMQF, Dr. Coudray is tasked with ensuring participant retention for the Minority and Rural Coronavirus Insights Study (MRCIS). Latrice Landry, PhD Instructor University of Pennsylvania Dr. Latrice Landry is a translational genomicist with training in epidemiology, bioinformatics, and clinical molecular genetics. Her research focuses on the systematic integration of multiple genomic modalities into molecular diagnostics to aid in clinical decision-making. Dr. Landry's process focuses on the use of bioinformatics pipelines as well as variant curation to incorporate genomic data in molecular diagnostics. Christina Edwards, MHA Director of Clinical Trials National Minority Quality Forum Christina Edwards began her academic career at Howard University, earning her Bachelor of Science. She later earned her Master of Health Administration from George Washington University Milken Institute School of Public Health. Years later she ventured into academic research at Weill Cornell Medicine, managing a multisite, NIH funded, pediatric study for children with Crohn's disease. Now serving as the Clinical Trial Director for Center for Clinical and Social Research at NMQF, she aims to increase research trial participation among underserved and underrepresented populations. Ola Akinboboye, MD, MPH, MBA, FACP, FACC, FAHA, FASNC, DABSM Medical Director Queens Heart Institute & Laurelton Heart Specialist PC Dr. Akinboboye is currently a Clinical Professor of Cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra-Northwell. He completed his medical education at the College of Medicine, University of Ibadan in 1984. He obtained a Master of Public Health Degree from the School of Public health at Columbia University in 1998. He also received a Master of Business Administration degree from Columbia University Business School in 2001. William A. Meyer III Ph.D, D(ABMM), MLS (ASCP) CM Medical and Technical Laboratory Consultant Quest Diagnostics Dr. Meyer is a Medical and Technical Laboratory Consultant for the entire Quest Diagnostics organization. He also has technical and consultative responsibility for the Clinical Pathology services provided in the Virology/Mycology/Molecular Biology areas for the Quest Diagnostics East Region facilities. Shantoy Hansel, MPH Research Associate National Minority Quality Forum Shantoy is a dedicated and accomplished researcher with a rich background in both laboratory sciences and public health epidemiology. Following her undergraduate studies, Shantoy immersed herself in various laboratory environments, gaining hands-on experience and honing her skills. In pursuit of deeper knowledge, she went on to obtain her Master's Degree in Public Health Epidemiology from the University of North Carolina at Charlotte (UNCC) in 2020.

Wisconsin is one of a few states with a Birth Cost Recovery program, which bills unmarried, non-custodial fathers for the birth costs of their child when the mother is on Medicaid. But the impacts of these policies on the children and both parents have not been studied closely.  In this episode, Dr. Tiffany Green discusses the report that she co-authored titled, “Effects Of Medicaid Birth Cost Recovery Policy Changes On Child Support Outcomes,” which draws on IRP's Wisconsin Administrative Data Core (WADC). Tiffany Green is an associate professor in the Departments of Population Health Sciences and Obstetrics and Gynecology within the School of Medicine and Public Health at the University of Wisconsin–Madison and is an IRP Affiliate.

In this episode of the MGMA Member Spotlight podcast, we're joined by Dr. Padma Gulur. Dr. Gulur is Professor of Anesthesiology and Professor in Population Health Sciences at Duke University School of Medicine. Dr. Gulur is also the 2023 MGMA Harwick Innovation Award winner. The Harwick Award is designed to recognize and celebrate the success of an individual who has developed an innovative solution that positively impacts practices, providers and/or patients in their community. Dr. Gulur was selected for the Harwick Award due to creating the Anesthesia Resource Management System (ARMS). According to the nomination, ARMS “has revolutionized the way (Duke Health) manages anesthesia resources, leading to remarkable operational efficiencies and substantial cost savings.” MGMA Leaders Conference We're sponsored by the MGMA Leaders Conference, which will be held in Nashville, TN, Oct 22-25. For more information go to MGMA.com/events. #MGMALeaders Additional Leaders Resources: MGMA Leaders Conference registration: mgma.com/conferences/leaders/register Leaders Conference Schedule: mgma.com/conferences/leaders/schedule Conference Overview: mgma.com/conferences/leaders/overview WE WANT TO HEAR FROM YOU Let us know if there's a topic you want us to cover or an expert you would like us to interview. Email us at podcasts@mgma.com. If you have opportunities and resources you'd like to share with MGMA members, go to Marketing with MGMA to find out how you can connect with the MGMA audience.

4:51 https://on.soundcloud.com/XNjqH Healthy Pastime: The personal and planetary health benefits of biking with scientist and Resources Chair for League of Women Voters in Los Angeles Dr. Grace Peng and Isabella Chu, Associate Director of the Data Core at Stanford's Center for Population Health Sciences. By Lindsay Sturman and Taylor Nichols. 32:41 https://on.soundcloud.com/eQiMF Business Bikelash: attachment to parking undermines livability and endangers the safe, healthy road design planned for Northampton, Massachusetts' Main Street. With Tony Jordan, President of the Parking Reform Network, and Elena Huisman, co-Founder of Main Street for Everyone. 49:41 https://on.soundcloud.com/CTsJq Yes: YIMBY Joanna Gubman connects land use, transportation, and environmentalism with bikes as Executive Director for Urban Environmentalists, a board member of the SF Bicycle Coalition, and Environmental Director at YIMBY Action. By Seamus Garrity.

The Theology, Medicine, and Culture Initiative (TMC) at Duke Divinity School and the Trent Center for Bioethics, Humanities & History of Medicine at Duke held a seminar on September 9, 2022 with Brett McCarty, ThD titled “Churches Promoting Recovery: Faith-Based Responses to Substance Use Issues.” Dr. McCarty is an Assistant Research Professor of Theological Ethics at Duke Divinity School; Associate Director of the Theology, Medicine, and Culture Initiative; and Assistant Professor in Population Health Sciences, Duke School of Medicine. TMC Seminars are a semi-monthly gathering of faculty, students, clinicians, and others interested in the intersections of theology, medicine, and culture. For more information and recordings, visit tmc.divinity.duke.edu/seminar/​.

Bioethicist Dr. Sarah Chan shares her thoughts on the ethics of human genome editing, the potential of developing a social model of enhancement, and the possibility of using biotechnology to improve the cognitive abilities of animals. Sarah Chan is a Chancellor's Fellow working in interdisciplinary bioethics at the Usher Institute for Population Health Sciences and Informatics, and Co-Director of the Mason Institute for Medicine, Life Sciences and Law, University of Edinburgh. Previously, from 2005 to 2015, she was a Research Fellow in Bioethics at the University of Manchester, first at the Centre for Social Ethics and Policy and from 2008 the Institute for Science Ethics and Innovation. Sarah's research focuses on the ethics of new biomedical technologies, including stem cell and embryo research; reproductive medicine; synthetic biology; gene therapy and genetic modification; and human and animal enhancement. Her current work draws on these interests to explore the ethics of emerging modes of biomedicine at the interface of health care research, medical treatment and consumer medicine including population-level health and genetic data research; the use of biomaterials in both research and treatment; and access to experimental treatments and medical innovation. Find out more: futurespodcast.net FOLLOW Twitter: twitter.com/futurespodcast Instagram: instagram.com/futurespodcast Facebook: facebook.com/futurespodcast ABOUT THE HOST Luke Robert Mason is a British-born futures theorist who is passionate about engaging the public with emerging scientific theories and technological developments. He hosts documentaries for Futurism, and has contributed to BBC Radio, BBC One, The Guardian, Discovery Channel, VICE Motherboard and Wired Magazine. Follow him on Twitter: twitter.com/lukerobertmason CREDITS Produced by FUTURES Podcast Recorded, Mixed & Edited by Luke Robert Mason

Dr. Natascha Merten joins the podcast to discuss her study focused on trends in cognitive function across generations. Merten also explains her research on the associations between sensory and motor functions and blood-based biomarkers for neurodegeneration and dementia. Guest: Natascha Merten, PhD, MS, director, Beaver Dam Offspring Study-Neurocognitive Aging Study, assistant professor, Departments of Population Health Sciences and Medicine, University of Wisconsin–Madison Show Notes Read Dr. Merten's studies, “Better cognitive function in younger generations - Insights from two cohort studies of middle-aged to older adults in Wisconsin,” and “Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer's disease in midlife,” through ScienceDirect. Read Dr. Merten's abstract from the 2022 Alzheimer's Association's International Conference through the journal Alzheimer's & Dementia. Read about Dr. Merten's R01 grant, “Dr. Natascha Merten Awarded NIA Funding To Study Sensory Changes Associated With Cognitive Change” on our website. Learn more about Dr. Merten in her bio on the University of Wisconsin Population Health Sciences website and on her Twitter @NataschaMerten. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter.

Brennan Francois, chief diversity officer for Augusta University Health, explains what medical mistrust is and how it affects patient-provider relationships, especially for Black Americans. He mentions what AU Health does to build trust within the community and how his role in the health system supports employees and patients. Also, Dr. Biplab Datta, assistant professor in the Institute of Public and Preventive Health and in the Department of Population Health Sciences, discusses the new edition of the Healthy Georgia Report, which highlights how Georgia compares to the Southeast and nation in over 20 diseases such as hypertension, cardiovascular disease, tobacco-smoking and more.

As COVID-19 swept through American prisons and jails in 2020, wardens scrambled to keep prisoners and corrections officers from getting sick. One strategy was to increase solitary confinement. Health experts warn that solitary confinement increases the risk of mental illness and suicide, but the practice continues. Today, about 2 million people are incarcerated in the U.S. In this episode of the Better Off podcast, we'll ask: Is it possible to build a corrections system that accounts for their health and safety? Guests:Jasmine D Graves, Ph.D. student, Population Health Sciences program, Harvard T.H. Chan School of Public HealthMonik Jimenez, Assistant Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public HealthCredits:Host/producer: Anna Fisher-PinkertThe Better Off team: Kristen Dweck, Elizabeth Gunner, Pamela Reynoso, Stephanie Simon, and Ben WallaceAudio engineering and sound design: Kevin O'ConnellAdditional research: Kate Becker

In the USA, Black  and Hispanic ovarian cancer patients experience much poorer outcomes than White patients, suggesting they have less access to quality care.  But why does this disparity exist, and what can be done to bridge this gap?Dr Akinyemiju, Associate Professor in Population Health Sciences at Duke University School of Medicine and Duke Cancer Institute, USA, is tackling these questions and  more in the Ovarian Cancer Epidemiology, Healthcare Access, and Disparities Study, or simply, ORCHiD.Read some of their latest work here:  http://dx.doi.org/10.1136/bmjopen-2021-052808

The coronavirus pandemic raised significant questions about public trust: trust in science, trust in politicians and trust in the public health messaging. Today Mark and his guests Anjana Ahuja; Sarah Cunningham-Burley; Charles Kwaku-Odoi and Christina Pagel discuss trust during the Covid-19 pandemic for this Going Viral special, produced in collaboration with the UK Pandemic Ethics Accelerator. Presented by Mark Honigsbaum @honigsbaum With: Anjana Ahuja Anjana Ahuja is a contributing writer on science for the Financial Times, offering weekly opinion on significant developments in global science, health and technology.  Last year she co-authored the bestselling ‘Spike: The Virus Vs The People' - the inside story of the Covid-19 pandemic with Sir Jeremy Farrar. Spike was shortlisted for the 2022 Orwell Prize for Political Writing and the 2022 Royal Society Science Book Prize. https://www.ft.com/anjana-ahuja  /  @anjahuja Professor Sarah Cunningham-Burley Sarah is Professor of Medical and Family Sociology and Dean of Molecular, Genetic and Population Health Sciences at the University of Edinburgh. Sarah led on work around engaging the public as part of the UK Pandemic Ethics Accelerator which finished its work in August 2022. She brought together members of the public to consider ethical issues arising during the Covid-19 pandemic. https://www.ed.ac.uk/profile/sarah-cunningham-burley / @Sarah_C_Burley  Rev Charles Kwaku-Odoi Charles is Chief Officer of the Caribbean and African Health Network (CAHN) and a Deputy Lieutenant (DL) of the county of Greater Manchester. Charles works to bring equity and fairness across a range of important health and wellbeing issues for people of the Caribbean and African Diaspora. He sits on a wide range of local and national governance boards including Macc (Manchester Community Central), Faith Network for Manchester, SAGE Ethnicity Subgroup, Greater Manchester Voluntary Community & Social Enterprise (VCSE) Leadership Group, Coalition of Race Equality (CORE) Organisations. www.cahn.org.uk  /  @charleskod Professor Christina Pagel Christina Pagel is a Mathematician and Professor of operational research at University College London within UCL's Clinical Operational Research Unit, which applies operational research, data analysis and mathematical modelling to topics in healthcare. https://iris.ucl.ac.uk/iris/browse/profile?upi=ACPAG88 / @chrischirp Series Producer: Melissa FitzGerald @Melissafitzg Co-producer: Kate Jopling  @katejopling Cover art by Patrick Blower. www.blowercartoons.com Follow us on Twitter: @GoingViral_pod     Follow us on Instagram: goingviral_thepodcast  This episode of Going Viral on trust during the pandemic, has been produced in collaboration with the UK Pandemic Ethics Accelerator, which was funded by the UKRI Covid-19 research and innovation fund. https://ukpandemicethics.org/ @PandemicEthics_ If you enjoy our podcast - please leave us a rating or review.  Thank you!  

Dr. Geraldine McGinty is professor of Clinical Radiology and Population Health Sciences and Senior Associate Dean for clinical affairs at Weill Cornell Medicine in New York. In this episode she shares her own journey and encourages medical students to build networks, know themselves, and be curious. Dr. McGinty studied medicine at the University of Galway and did her residency at the University of Pittsburgh Medical Center where she was chief resident. She is an expert in imaging economics and an attending radiologist at New York-Presbyterian Hospital, specializing in breast imaging. She has served as an advisor to the CPT Editorial Panel and the National Quality Forum. She was Chair of the American College of Radiology's Commission on Economics and was the radiology member of the AMA's Relative Value Update Committee from 2012-2016. From 2014-2021 Dr. McGinty served as a Non-Executive Director of IDA Ireland, the national foreign direct investment agency. In May 2018 she was elected as the Chair of the ACR's Board of Chancellors, the first woman to hold this office. Dr. McGinty was president of the ACR from 2020-2021. Find her @DrGMcGinty on Twitter

Dr. Angela Fagerlin, chair of the Department of Population Health Sciences at University of Utah Health joins Lisa Dent to explain a survey she led, that revealed that 40% of Americans were often less than truthful about whether they had COVID-19, or have taken the vaccine.  Follow Your Favorite Chicago’s Afternoon News Personalities on Twitter:Follow @LisaDentSpeaksFollow […]

In today's episode, we chat with Alejandra Salemi, MPH, MTS, who is currently a Doctoral Student in Population Health Sciences at Duke University. Alejandra is interested in understanding the intersection of religion, community health and wellbeing. She is someone with experience using her coaching skillsets to help people around their health and wellness. She got her Bachelors in Public Health at University of Florida. She then got her Master of Public Health at University of Florida followed by her Master of Theological Studies at Harvard University. And is currently working towards a doctoral degree at Duke University.Shownotes: https://thephmillennial.com/episode119Join Community Health & Wellness Discord: https://www.thephmillennial.com/joinAlejandra Salemi, MPH, MTS on LinkedIn: https://www.linkedin.com/in/alejandrasalemi0315/Omari on IG: https://www.instagram.com/thephmillennial Omari on LinkedIn: https://www.linkedin.com/in/omari-richins All ways to support The Public Health Millennial: https://thephmillennial.com/support/ Shop at The Public Health Store: https://thephmillennial.com/shop/Chapters:0:00 - Teaser clip0:39 - Public Health careers podcast intro1:10 - Episode intro3:02 - How are you doing?4:00 - Personal Background5:35 - What does Public Health mean to you?5:36 - Shop ad6:15 - Back to episode7:54 - Journey in Public Health11:24 - How did you know you wanted to do Public Health13:19 - How did you choose your concentration?14:55 - Position as Cognito Program Ambassador @ UF Counseling and Wellness Center19:58 - Takeaways from time in schooling22:34 - Masters in Theological studies @ Harvard28:45 - Concentration at Harvard31:03 - Team Lead role at Harvard34:34 - What made you switch masters programs?36:12 - Position as Research assistant at FXB centre at Harvard41:03 - Position as Research assistant at Harvard TH Chan School of Public Health45:00 - Do you think you git what you wanted from your Masters degree46:50 - Current time as PhD student at Duke51:05 - Discord ad51:52 - Back to episode54:56 - How can someone start their own platform58:47 - Where so you see yourself in the future?1:00:45 - Advice for students pursuing public health1:01:41 - Advice for someone wanting to be where you are1:03:18 - What is something you're working on improving right now?1:04:10 - Professional recommendations1:05:15 - Where can people connect with you?Support the show

Population Health Sciences and Epidemiology are thought about as different from one another by some, and largely overlapping by others. Depending on who you talk to, either view might spark an argument. In this crossover episode, I get the chance to chat with Aresha Martinez-Cardoso, Darrell Hudson, and Michael Esposito, hosts of the IAPHS podcast. We may or may not actually answer the question: what's the difference between these two fields anyway?

Iveris Martinez (Iveirs.Martinez@csulb.edu) is Archstone Foundation Endowed Chair in Gerontology and Director of the Center for Successful Aging at California State University, Long Beach. She received a joint PhD in Anthropol­ogy and Population Health Sciences from the Johns Hopkins University. An applied anthropologist, she has been working in the fields of public health, medicine, and aging since 1997. Between 2007 and 2018, she developed and taught courses on cultural competency, social determinants of health, and interprofessional teamwork for Wertheim College of Medicine at Florida International University. She is co-editor of Anthropology in Medical Education: Sustaining Engagement and Impact (Springer, 2021). https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.springer.com%2Fus%2Fbook%2F9783030622763&data=05%7C01%7CJake.Lancaster%40BMHCC.org%7C01e7183e77744049eed708da3cdb46b1%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637889209719058645%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=28k%2FIYpx83lp9JkEXP5KlC5%2FCtQub4HnxQh%2BxfSf5Gw%3D&reserved=0 (https://www.springer.com/us/book/9783030622763) Dr. Martinez has received funding from the National Institutes of Health, the Macarthur Foundation, and others for her research on social and cultural factors influencing health, with an emphasis in aging, Latinos, and minority populations. Her current interests include interprofessional workforce development for meeting the needs of an increasingly diverse aging population. Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3 (https://www.surveymonkey.com/r/3DXCFW3) CME credit is available for up to 3 years after the stated release date Contact CEOD@bmhcc.org if you have any questions about claiming credit.

Joseph Osmundson, microbiologist, activist, writer, and author of Virology: Essays for the Living, the Dead, and the Small Things in Between (W. W. Norton & Company, 2022) and Jay Varma, physician and epidemiologist, director of the Cornell Center for Pandemic Prevention and Response and professor of Population Health Sciences at Weill Cornell Medicine, share updates on the monkeypox outbreak and the public health response as New York City joins the state in declaring the spread of the virus a public health emergency.

Jay Varma, physician and epidemiologist, director, Cornell Center for Pandemic Prevention and Response, professor of Population Health Sciences at Weill Cornell Medicine talks about the latest wave of cases caused by BA.5, the possibility of an Omicron-specific booster shot this fall and more COVID news.

Jay Varma, physician and epidemiologist, director, Cornell Center for Pandemic Prevention and Response, professor of Population Health Sciences at Weill Cornell Medicine, talks about the expected announcement that unvaccinated athletes will be allowed to play in NYC, including Nets star Kyrie Irving.

Dr. Amelie Ramirez is Director of the Institute for Health Promotion Research, Chair of the Department of Population Health Sciences, and Associate Director of Cancer Outreach and Engagement at the Mayes Cancer Center at the University of Texas at San Antonio.The institute that Dr. Ramirez leads is the headquarters for Salud America!, a national program that uses innovative evidence-based research and communications to educate and activate an online network of more than 300,000 advocates to promote healthy change in equity for Latino and all families.  Dr. Ramirez has also personally trained and mentored over 300 Latino undergraduate pre-and post-doctoral students.  Her recognitions include a 2007 election to the National Academy of Medicine, a 2011 White House Champion of Change, the Everett M. Rogers Public Health Communication Award from the American Public Health Association, a Lifetime Achievement Award from the Society of Behavioral Medicine.She's also on the San Antonio Mayor's Fitness Council as President of the Academy of Medicine, Engineering, and Sciences of Texas. Follow Salud America on Twitter: @SaludAmerica 

Mary Alice Scott is a medical anthropologist and faculty member at New Mexico State University and the Southern New Mexico Family Medicine Residency Program. Her research focuses on cultures of medicine and medical education, health disparities in the U.S.-Mexico border region, and social medicine training in primary care. Iveris Martinez (Iveirs.Martinez@csulb.edu) is Archstone Foundation Endowed Chair in Gerontology and Director of the Center for Successful Aging at California State University, Long Beach. She received a joint PhD in Anthropol­ogy and Population Health Sciences from the Johns Hopkins University. An applied anthropologist, she has been working in the fields of public health, medicine, and aging since 1997. Between 2007 and 2018, she developed and taught courses on cultural competency, social determinants of health, and interprofessional teamwork for Wertheim College of Medicine at Florida International University. She is co-editor of Anthropology in Medical Education: Sustaining Engagement and Impact (Springer, 2021). https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.springer.com%2Fus%2Fbook%2F9783030622763&data=04%7C01%7CJake.Lancaster%40BMHCC.org%7C8a9bbb4095a74c649afd08d9dce2b364%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637783688491706292%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=lumxXKF5VuEqon%2F0fidAV4nzowgi%2B2rOuEPYEpWgJfI%3D&reserved=0 (https://www.springer.com/us/book/9783030622763) Dr. Martinez has received funding from the National Institutes of Health, the Macarthur Foundation, and others for her research on social and cultural factors influencing health, with an emphasis in aging, Latinos, and minority populations. Her current interests include interprofessional workforce development for meeting the needs of an increasingly diverse aging population. Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3 (https://www.surveymonkey.com/r/3DXCFW3) CME credit is available for up to 3 years after the stated release date Contact CEOD@bmhcc.org if you have any questions about claiming credit.

In 2021 state-based abortion restrictions swelled across the country and a powerful challenge to Roe v Wade, the Supreme Court decision that protects a pregnant person's right to choose to have an abortion, will be decided in the Supreme Court this year. All admist a backdrop of pervasive disparities in access to family planning, prenatal care, and maternal and child mortality across race/ethnicity and socioeconomic status. In this episode, we're joined by Dr. Tiffany Green, Assistant Professor in the Departments of Population Health Sciences and Obstetrics & Gynecology at UW-Madison, and Dr Lina Maria Murillo, Assistant Professor in the Departments of Gender, Women's and Sexuality Studies, History, and Latina/o/x Studies at the University of Iowa, to help us understand the history of reproductive rights and justice and what might lie ahead given the current policy context.

Dr. Tiffany Green is an assistant professor in the Departments of Population Health Sciences and Obstetrics and Gynecology at the University of Wisconsin-Madison. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Green and A.S. Venkataramani. Trade-offs and Policy Options — Using Insights from Economics to Inform Public Health Policy. N Engl J Med 2022;386:405-408.

Dr. Tiffany Green is an Assistant Professor at the University of Wisconsin Schools of Public Health and Medicine in the Departments of Population Health Sciences and Obstetrics and Gynecology. Her work focuses on improving outcomes and saving the lives of Black birthing people and their infants from her powerful and unique view as an economist. She is also an alumna of the Get That Grant coaching program! Take a listen to hear some real behind the scenes of her coaching journey: Being a seasoned grant writer, but lacking both clarity and adequate boundaries How a skeptic of ‘self-help' experienced profound transformation in a coaching program The moment where a little tough love went a long way Why she describes the Get That Grant coaching program as a ‘trojan horse'!  The primary characteristic of the fellow faculty in her coaching cohort that led to such a profound connection  If you loved this convo, please go find Tiffany on Twitter (@Tiffany_L_Green) and show her some love! 

Our ability to grow and learn from error is as human as the errors themselves. For part 3 of our series on Failure in Medicine, we focus on how medical trainees and professionals can better learn from their mistakes. We talk with Dr. Peter Weir, whose work in health system innovation within the departments of Family & Preventive Medicine and Population Health Sciences at the University of Utah inspired him to write a piece entitled “How to Learn from Failure” outlining common types of failure medical trainees experience and what each of these can teach us.Find Dr. Weir's piece here: https://accelerate.uofuhealth.utah.edu/leadership/peter-weir-how-medicine-can-learn-from-failureAnd go check out Dr. Weir's podcast, Communivation: https://accelerate.uofuhealth.utah.edu/connect/communivation

In today's episode, Tim Suther is joined by Dr. Mark Cullen, who's been at the forefront of population health for decades—even before it was a recognized field. Listen in as Tim and Dr. Cullen discuss the collaborative effort that has gone into the COVID-19 Research Database, and what the resulting research and analysis can tell us about vaccine effectiveness, breakthrough infections, social determinants of health (SDoH), and booster vaccines. Today's panel includes: Dr. Mark Cullen, consultant in population health and the Founding Director of the Stanford Center for Population Health Sciences; and Tim Suther, senior vice president, data solutions at Change Healthcare. Here's what they chatted about: What data can tell us about COVID-19 vaccine effectiveness and breakthroughs, and what it can't. What's behind vaccine hesitancy and where we go from here. How social determinants of health (SDoH) and pre-existing conditions have affected infection and mortality rates.    

As we follow innovation along the R&D value chain, we come across some compelling contributions to the healthcare ecosystem.Venture capital investors. Causal inference. Real world evidence.In this episode, we interview three guests about a collaboration story that represents the best of a healthy healthcare ecosystem:Janis Naeve, Managing Director, Amgen Ventures at Amgen and Incubate Board TreasurerBrian Bradbury , Vice President of Center for Observational Research at Amgen and Adjunct Professor of Epidemiology at UCLAAlan Brookhart, Founder and Chief Scientist at NoviSci and Professor of Population Health Sciences at Duke UniversityIn this episode we discuss:How Amgen fosters relationships among scientistsThe difference between machine learning and causal inferenceThe origin story of NoviSciHow COVID has affected a fruitful partnershipAs we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what's top of mind, what story you want to hear, or what you find interesting!To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform. Listening on a desktop & can't see the links? Just search for Making Medicine in your favorite podcast player.

Tonight, the Perpetual Notion Machine continues the analysis of the current Intergovernmental Panel on Climate Change (IPCC) assessment report. Our guest is Jonathan Patz, who studies the environmental health effects from climate change on the population in the Nelson Institute of Environmental Studies and the Department of Population Health Sciences at UW-Madison. He is also […] The post Latest IPCC Report – Climate Change is “Unequivocal”... appeared first on WORT 89.9 FM.

It's back to school season and this week on the VSC Podcast we are sharing a panel we held for Sexual Assault Awareness Month back in April of 2021 which was all about Preventing Sexual Assault on Campus. Join VSC Education Coordinator Emilie Mitchell and VSC Education Intern Roxane Perret along with four amazing panelists: Rollin's Title IX Coordinator Sarah Laake, UCF Victim Services Advocate Jessica Baker, UCF Assistant Professor Julia O'Connor, and VSC Victim Advocate Kevin Fox as they discuss addressing rape culture on campus, the red zone and other statistics, barriers members of the BIPOC and LGBTQ+ communities face, and ways we can help change the culture and promote safe spaces on campus. Sarah uses she/her pronouns and is the Director of the Title IX office of Rollins College. Sarah has 15 years of experience working in the non-profit and higher education sectors as an advocate creating environments free from violence and discrimination. Julia uses she/her pronouns and is an assistant professor at the University of Central Florida in the School of Social Work. She is also a member of the Violence Against Women faculty cluster, and has a secondary appointment in the Department of Population Health Sciences. Jessica uses she/her pronouns and is a Victim Advocate at UCF Victim Services since 2018. Prior to her current role, Jessica was a Victim Advocate at the State Attorney's Office in the 9th Judicial Circuit working in the Domestic Violence Unit's Felony Division. Kevin uses he/him pronouns and is a Victim advocate in an adjunct position with the VSC and Zebra Coalition serving survivors in the LGBTQ+ Community. Kevin worked as a high school teacher while receiving his Master of Arts in Clinical Mental Health Counseling from Rollins College. You can listen to this episode on our Youtube Channel: https://youtu.be/o_NNBNfKI7o You can also listen to this episode on Apple Podcasts, Spotify, or wherever you get your podcasts! Want to make a difference? Visit Victimservicecenter.org to learn how you can get involved and help the VSC continue supporting survivors of trauma. ----------------------------------- Trigger Warning: In this podcast we will be discussing sensitive topics such as Sexual Assault. It's important to take care of yourself while listening. Some suggestions are listening while you're in a healthy head space or knowing who you can reach out to if you become upset. Our 24/7 helpline for crisis calls based out of Central Florida is 407 500 HEAL, for the Florida state sexual helpline call (888) 956-7273. By contacting the National Hotline at 1-800-656-4673 you can get support and learn about your local resources. There is always someone ready to help.

Listen to the highlights of our series finale, recorded live on 21 July 2021. Hosted by UCL alumna, broadcaster and writer, Vivienne Parry OBE, our global audience put their questions to the experts.Guests:- Professor Dame Anne Johnson (Professor of Infectious Disease, Division of Infection & Immunity, UCL Faculty of Medical Sciences and Faculty of Population Health Sciences). Adviser to the SAGE committee.- Professor Deenan Pillay (Professor of Virology, Division of Infection & Immunity, UCL Faculty of Medical Sciences). Adviser to the Independent SAGE committee.- Professor Susan Michie (Professor of Health Psychology, Clinical, Educational & Health Psychology, Division of Psychology & Language Sciences, UCL Faculty of Brain Sciences). Adviser to the Sage and Independent SAGE committees.- Professor Andrew Hayward (Professor of Infectious Disease Epidemiology and Inclusion Health Research, UCL Institute of Epidemiology & Health). Adviser to the Sage and Nervtag committees.Find out more: www.ucl.ac.uk/ucl-minds/coronavirusView the transcript: www.ucl.ac.uk/ucl-minds/podcasts…nscript-episode-53 See acast.com/privacy for privacy and opt-out information.

Listen to the highlights of our series finale, recorded live on 21 July 2021. Hosted by UCL alumna, broadcaster and writer, Vivienne Parry OBE, our global audience put their questions to the experts. Guests: - Professor Dame Anne Johnson (Professor of Infectious Disease, Division of Infection & Immunity, UCL Faculty of Medical Sciences and Faculty of Population Health Sciences). Adviser to the SAGE committee. - Professor Deenan Pillay (Professor of Virology, Division of Infection & Immunity, UCL Faculty of Medical Sciences). Adviser to the Independent SAGE committee. - Professor Susan Michie (Professor of Health Psychology, Clinical, Educational & Health Psychology, Division of Psychology & Language Sciences, UCL Faculty of Brain Sciences). Adviser to the Sage and Independent SAGE committees. - Professor Andrew Hayward (Professor of Infectious Disease Epidemiology and Inclusion Health Research, UCL Institute of Epidemiology & Health). Adviser to the Sage and Nervtag committees. Find out more: https://www.ucl.ac.uk/ucl-minds/coronavirus View the transcript: https://www.ucl.ac.uk/ucl-minds/podcasts/coronavirus/transcript-episode-53

Host: Ana Maria Rosario Guest: Dr. Patricia M. Boatwright, MD As any healthcare professional would agree, being passionate about your practice is key to having a good relationship with your patients. But choosing a specific specialty isn't always an easy or clear decision. Joining Ana Maria Rosario to share how she came to her decision and a few experiences that made her into the healthcare professional she is today is Dr. Patricia Boatwright, an ob-gyn and Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine.

Host: Ana Maria Rosario Guest: Dr. Patricia M. Boatwright, MD As any healthcare professional would agree, being passionate about your practice is key to having a good relationship with your patients. But choosing a specific specialty isn't always an easy or clear decision. Joining Ana Maria Rosario to share how she came to her decision and a few experiences that made her into the healthcare professional she is today is Dr. Patricia Boatwright, an ob-gyn and Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine.

Dr. Said Ibrahim is the Inaugural Senior Associate Dean for Diversity and Inclusion, Professor of Population Health Sciences at Weill Cornell Medicine, and an NIH funded clinical investigator, focusing on unequal health care access and quality among underserved communities. He joins us for a discussion on diversity in healthcare and how it impacts care outcomes and delivery of care. We also cover: (7:56) the big difference between health equity and health equality, (12:06) how implicit bias impacts healthcare and Dr. Singh discovers his own implicit bias, (19:32) achieving a diverse healthcare workforce, (27:03) changing how healthcare is delivered, and (30:15) study results and an interesting example of cultural differences.  Learn more about Dr. Ibrahim here: https://vivo.weill.cornell.edu/display/cwid-sai2009

This episode features Dr Lucy Selman  (Palliative and End of Life Care Research Group, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK). Twitter is a rich repository of data reflecting contemporaneous public opinion. The idea of dying alone is contrary to the concept of a ‘good death' in many cultures, and not being able to say goodbye is a known risk factor for poor bereavement outcomes. During the COVID-19 pandemic, many bereaved people have been unable to be present when their loved one died due to setting-specific infection control restrictions that vary across regions and institutions. Twitter users expressed sadness, despair, hopelessness and anger about their experience and loss during the COVID-19 pandemic, with the challenges they experienced before the death compounded by a lack of social support and disrupted rituals afterwards. A sense of political neglect or mistreatment was frequently expressed, alongside calls for action, but Twitter users also used the platform to encourage positive public health messages, express condolences to and support others, and pay tribute to the deceased. There was ambivalence about the use of video-conferencing technology, which was often presented as an inadequate substitute, and frustration and blame were directed at governments' inaction and policies as well as the behaviour of the general public. Governments should provide clear guidance to support end-of-life care providers in facilitating and optimising contact with loved ones, even when strict visiting policies are necessary; this must include adequate access to personal protective equipment. Signposting bereaved family members and friends to bereavement services, and proactively identifying and supporting those at particular risk of poor outcomes, is as crucial during a pandemic, as it is in non-pandemic times. Further research is needed to fully understand the emotional toll expressed in these tweets and the immediate and sustained impacts of bereavement during the pandemic.

This episode features Dr Lucy Selman  (Palliative and End of Life Care Research Group, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK). During COVID-19, infection control measures have prevented many family members from being with seriously ill or dying loved ones, and impacted on after-death mourning practices and bereavement. Clinicians and funeral officiants have tried to mitigate the impact of infection control measures, for example, using video-technology; however, this has not been done consistently and its acceptability is unknown. The news media play an important role in creating a sense-making narrative, reflecting and enforcing cultural ideas and shaping experiences of illness and bereavement. Online UK newspapers focused on how COVID-19 disrupted ‘saying goodbye' (prior to death, at the moment of death and after death) and conflicted with cultural understandings of a ‘good death' and ‘good grief', despite efforts undertaken to mitigate the effects of restrictions. Findings demonstrate a prevailing uncertainty, fear and anxiety regarding: changes to practice; control over access to people who have been hospitalised; the possibility of dying alone or having loved ones die alone; and being unable to properly commemorate a death. Articles focused on what was forbidden rather than permitted and offered little practical guidance for the public. Understanding the media representations and cultural narratives around a ‘good death' and ‘good grief' that influence patients' and families' fears and anxieties can help inform person-centred care and bereavement support. Clinicians should explore with families ways of finding meaningful connection and of saying goodbye despite restrictions, and, alongside other bereavement support providers and hospital press officers, should offer alternatives to exaggerated or inaccurate media narratives. More could be done in media reporting to portray diverse experiences and offer practical advice to members of the public dealing with serious illness and bereavement during the pandemic.

Plant-based and/or fish diets may help lessen severity of COVID-19 infection   Johns Hopkins University, June 8, 2021 Plant-based and/or fish (pescatarian) diets may help lower the odds of developing moderate to severe COVID-19 infection, suggest the findings of a six-country study, published in the online journal BMJ Nutrition Prevention & Health. They were associated with 73% and 59% lower odds, respectively, of severe disease, the findings indicate. Several studies have suggested that dietmight have an important role in symptom severity and illness duration of COVID-19 infection. But, as yet, there's little evidence to confirm or refute this theory. To explore this further, the researchers drew on the survey responses of 2884 frontline doctors and nurses with extensive exposure to SARS-CO-v2, the virus responsible for COVID-19 infection, working in France, Germany, Italy, Spain, the UK and the US. The participants were all part of a global network of healthcare professionals registered with the Survey Healthcare Globus network for healthcare market research. The researchers used this network to identify clinicians at high risk of COVID-19 infection as a result of their jobs. The online survey, which ran between July and September 2020, was designed to elicit detailed information about respondents' dietary patterns, based on a 47-item food frequency questionnaire, over the previous year, and the severity of any COVID-19 infections they had had, using objective criteria. The survey also gathered information on personal background, medical history, medication use, and lifestyle. The various diets were combined into plant-based (higher in vegetables, legumes, and nuts, and lower in poultry and red and processed meats); pescatarian/plant-based (as above, but with added fish/seafood); and low carb-high protein diets. Some 568 respondents (cases) said they had had symptoms consistent with COVID-19 infection or no symptoms but a positive swab test for the infection; 2316 said they hadn't had any symptoms/tested positive (comparison group). Among the 568 cases, 138 clinicians said they had had moderate to severe COVID-19 infection; the remaining 430 said they had had very mild to mild COVID-19 infection. After factoring in several potentially influential variables, including age, ethnicity, medical specialty, and lifestyle (smoking, physical activity), respondents who said they ate plant-based diets' or plant-based/pescatarian diets had, respectively, 73% and 59% lower odds of moderate to severe COVID-19 infection, compared with those who didn't have these dietary patterns. And compared with those who said they ate a plant-based diet, those who said they ate a low carb-high protein diet had nearly 4 times the odds of moderate to severe COVID-19 infection. These associations held true when weight (BMI) and co-existing medical conditions were also factored in. But no association was observed between any type of diet and the risk of contracting COVID-19 infection or length of the subsequent illness. This is an observational study, and so can't establish cause, only correlation. It also relied on individual recall rather than on objective assessments, and the definition of certain dietary patterns may vary by country, point out the researchers. Men outnumbered women in the study, so the findings may not be applicable to women, they add. But plant-based diets are rich in nutrients, especially phytochemicals (polyphenols, carotenoids), vitamins and minerals, all of which are important for a healthy immune system, say the researchers. And fish is an important source of vitamin D and omega-3 fatty acids, both of which have anti-inflammatory properties, they add. "Our results suggest that a healthy diet rich in nutrient dense foods may be considered for protection against severe COVID-19," they conclude. "The trends in this study are limited by study size (small numbers with a confirmed positive test) and design (self-reporting on diet and symptoms) so caution is needed in the interpretation of the findings," comments Deputy Chair of the NNEdPro Nutrition and COVID-19 Taskforce, Shane McAuliffe. "However, a high quality diet is important for mounting an adequate immune response, which in turn can influence susceptibility to infection and its severity." He adds:"This study highlights the need for better designed prospective studies on the association between diet, nutritional status and COVID-19 outcomes."   Greater magnesium intake associated with reduced hostility among young adults Columbia University, June 4, 2021   According to news originating from New York City, New York, research stated, “Hostility is a complex personality trait associated with many cardiovascular risk factor phenotypes. Although magnesium intake has been related to mood and cardio-metabolic disease, its relation with hostility remains unclear.” Our news journalists obtained a quote from the research from Columbia University, “We hypothesize that high total magnesium intake is associated with lower levels of hostility because of its putative antidepressant mechanisms. To test the hypothesis, we prospectively analyzed data in 4,716 young adults aged 18-30 years at baseline (1985-1986) from four U.S.cities over five years of follow-up using data from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Magnesium intake was estimated from a dietary history questionnaire plus supplements at baseline. Levels of hostility were assessed using the Cook-Medley scale at baseline and year 5 (1990-1991). Generalized estimating equations were applied to estimate the association of magnesium intake with hostility as repeated measures at the two time-points (baseline and year 5). General linear model was used to determine the association between magnesium intake and change in hostility over 5 years. After adjustment for socio-demographic and major lifestyle factors, a significant inverse association was observed between magnesium intake and hostility level over 5 years of follow-up. Beta coefficients (95% CI) across higher quintiles of magnesium intake were 0 (reference),-1.28 (-1.92,-0.65),-1.45 (-2.09,-0.81),-1.41 (-2.08,-0.75) and-2.16 (-2.85,-1.47), respectively (Plinear-trend < .01).” According to the news editors, the research concluded: “The inverse association was inde-pendent of socio-demographic and major lifestyle factors, supplement use, and depression status at year 5. This prospective study provides evidence that in young adults, high magne-sium intake was inversely associated with hostility level independent of socio-demographic and major lifestyle factors.”       Study compares heart benefits of low-fat and plant-centered diets New findings suggest that a plant-centered diet could help lower heart disease risk University of Minnesota, June 7, 2021 There has been a long-standing debate as to whether a low-fat or a plant-centered diet is better at lowering the risk of cardiovascular disease. A new study that followed more than 4,700 people over 30 years, found that a plant-centered diet was associated with a lower long-term risk for cardiovascular disease. However, both diets were linked with lower LDL, or bad cholesterol, levels.  "Since 1980, dietary guidelines in the United States and in Europe have recommended eating low amounts of saturated fat because of the high rates of heart disease in these regions," said research team leader David Jacobs, PhD, from the University of Minnesota. "This is not necessarily wrong, but our study shows that plant-centered diets can also lower bad cholesterol and may be even better at addressing heart disease risk." The plant-centered diet emphasizes fruit, vegetables, legumes, whole grains, nuts and seeds, low-fat dairy, and fish. It also limits high-fat red and processed meats, salty snacks, sweets, and sugar-sweetened soft drinks. The low-fat diet is based on the Keys Score, a good formulation of the "low saturated fat" message, driven by saturated fat, but also including polyunsaturated fat and dietary cholesterol. Yuni Choi, PhD, a postdoctoral fellow in Jacobs' lab will present the research as part of NUTRITION 2021 LIVE ONLINE, a virtual conference hosted by the American Society for Nutrition (ASN).  "Our findings show that it is important to view diet quality from a holistic perspective," said Choi. "Targeting just single nutrients such as total or saturated fat doesn't take into account the fats that are also found in healthy plant-based foods such as avocado, extra virgin olive oil, walnuts and dark chocolate -- foods that also have cardioprotective properties and complex nutrient profiles." The new research is based on participants in the four U.S. clinics of the Coronary Artery Risk Development in Young Adults study (CARDIA), which enrolled 5115 Black and white men and women in 1985-1986. During more than 30 years of follow up, there were 280 cases of cardiovascular disease, 135 cases of coronary heart disease, and 92 cases of stroke among the study participants.  To assess eating patterns, the researchers conducted three detailed diet history interviews over the follow-up period. These diet history questionnaires determined what participants ate and then asked them to list everything consumed in that category. For example, participants who reported eating meat in the past 30 days would be asked what meat items and how much they consumed. This was repeated for around 100 areas of the diet. Based on this information, the researchers calculated scores for all participants based on both the Keys Score of the A Priori Diet Quality Score (APDQS), which captures the plant-centered diet.  After accounting for various factors including socioeconomic status, educational level, energy intake, history of cardiovascular disease, smoking and body mass index, the researchers found that having a more plant-centered diet (higher APDQS Scores) and consuming less saturated fat (lower Keys Scores) were both associated with lower LDL levels. However, lower LDL levels did not necessarily correlate with lower future risk of stroke. Higher APDQS scores, but not lower Keys Scores, were strongly associated with a lower risk for coronary heart disease and stroke. "Based on our study, we suggest that people incorporate more nutritionally-rich plant foods into their diets," said Choi. "One way to do this is to fill 70 percent of your grocery bag with foods that include vegetables, fruits, whole grains, nuts, legumes, coffee and tea." The researchers are carrying out a variety of studies looking at how the APDQS diet score relates to various health outcomes. They are also interested in studying how different diets affect gut bacteria, which is known to influence many aspects of health and disease.       High caffeine consumption may be associated with increased risk of blinding eye disease Mount Sinai School of Medicine, June 7, 2021 Consuming large amounts of daily caffeine may increase the risk of glaucoma more than three-fold for those with a genetic predisposition to higher eye pressure according to an international, multi-center study. The research led by the Icahn School of Medicine at Mount Sinai is the first to demonstrate a dietary - genetic interaction in glaucoma. The study results published in the June print issue of Ophthalmology may suggest patients with a strong family history of glaucoma should cut down on caffeine intake.  The study is important because glaucoma is the leading cause of blindness in the United States. It looks at the impact of caffeine intake on glaucoma, and intraocular pressure (IOP) which is pressure inside the eye. Elevated IOP is an integral risk factor for glaucoma, although other factors do contribute to this condition. With glaucoma, patients typically experience few or no symptoms until the disease progresses and they have vision loss. "We previously published work suggesting that high caffeine intake increased the risk of the high-tension open angle glaucoma among people with a family history of disease. In this study we show that an adverse relation between high caffeine intake and glaucoma was evident only among those with the highest genetic risk score for elevated eye pressure," says lead/corresponding author Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Mount Sinai Health System. A team of researchers used the UK Biobank, a large-scale population-based biomedical database supported by various health and governmental agencies. They analyzed records of more than 120,000 participants between 2006 and 2010. Participants were between 39 and 73 years old and provided their health records along with DNA samples, collected to generate data. They answered repeated dietary questionnaires focusing on how many caffeinated beverages they drink daily, how much caffeine-containing food they eat, the specific types, and portion size. They also answered questions about their vision, including specifics on if they have glaucoma or a family history of glaucoma. Three years into the study later they had their IOP checked and eye measurements. Researchers first looked at the relationship looked between caffeine intake, IOP and self-reported glaucoma by running multivariable analyses. Then they assessed if accounting for genetic data modified these relationships. They assigned each subject an IOP genetic risk score and performed interaction analyses.  The investigators found high caffeine intake was not associated with increased risk for higher IOP or glaucoma overall; however, among participants with the strongest genetic predisposition to elevated IOP - in the top 25 percentile - greater caffeine consumption was associated with higher IOP and higher glaucoma prevalence. More specifically, those who consumed the highest amount of daily caffeine- more than 480 milligrams which is roughly four cups of coffee - had a 0.35 mmHg higher IOP. Additionally, those in the highest genetic risk score category who consumed more than 321 milligrams of daily caffeine - roughly three cups of coffee - had a 3.9-fold higher glaucoma prevalence when compared to those who drink no or minimal caffeine and in lowest genetic risk score group.  "Glaucoma patients often ask if they can help to protect their sight through lifestyle changes, however this has been a relatively understudied area until now. This study suggested that those with the highest genetic risk for glaucoma may benefit from moderating their caffeine intake. It should be noted that the link between caffeine and glaucoma risk was only seen with a large amount of caffeine and in those with the highest genetic risk," says co-author Anthony Khawaja, MD, PhD, Associate Professor of Ophthalmology University College London (UCL) Institute of Ophthalmology and ophthalmic surgeon at Moorfields Eye Hospital. "The UK Biobank study is helping us to learn more than ever before about how our genes affect our glaucoma risk and the role that our behaviors and environment could play. We look forward to continuing to expand our knowledge in this area."   Red onions pack a cancer-fighting punch, study reveals University of Guelph (Ontario), June 7, 2021 The next time you walk down the produce aisle of your grocery store, you may want to reach for red onions if you are looking to fight off cancer. In the first study to examine how effective Ontario-grown onions are at killing cancer cells, U of G researchers have found that not all onions are created equal. Engineering professor Suresh Neethirajan and PhD student Abdulmonem Murayyan tested five onion types grown in Ontario and discovered the Ruby Ring onion variety came out on top. Onions as a superfood are still not well known. But they contain one of the highest concentrations of quercetin, a type of flavonoid, and Ontario onions boasts particularly high levels of the compound compared to some parts of the world. The Guelph study revealed that the red onion not only has high levels of quercetin, but also high amounts of anthocyanin, which enriches the scavenging properties of quercetin molecules, said Murayyan, study's lead author. "Anthocyanin is instrumental in providing colour to fruits and vegetables so it makes sense that the red onions, which are darkest in colour, would have the most cancer-fighting power." Published recently in Food Research International, the study involved placing colon cancer cells in direct contact with quercetin extracted from the five different onion varieties. "We found onions are excellent at killing cancer cells," said Murayyan. "Onions activate pathways that encourage cancer cells to undergo cell death. They promote an unfavourable environment for cancer cells and they disrupt communication between cancer cells, which inhibits growth." The researchers have also recently determined onions are effective at killing breast cancer cells. "The next step will be to test the vegetable's cancer-fighting powers in human trials," said Murayyan. These findings follow a recent study by the researchers on new extraction technique that eliminates the use of chemicals, making the quercetin found in onions more suitable for consumption. Other extraction methods use solvents that can leave a toxic residue which is then ingested in food, said Neethirajan. "This new method that we tested to be effective only uses super-heated water in a pressurized container," he said. "Developing a chemical-free extraction method is important because it means we can use onion's cancer-fighting properties in nutraceuticals and in pill form." While we can currently include this superfood in salads and on burgers as a preventative measure, the researchers expect onion extract will eventually be added to food products such as juice or baked goods and be sold in pill form as a type of natural cancer treatment.     Exercise likely to be best treatment for depression in coronary heart disease   RCSI University of Medicine and Health Sciences (Ireland), June 8, 2021 A study by RCSI indicates that exercise is probably the most effective short-term treatment for depression in people with coronary heart disease, when compared to antidepressants and psychotherapy or more complex care.  The study, led by researchers at RCSI University of Medicine and Health Sciences, is published in the June edition of Psychosomatic Medicine.  This is the first systematic review to compare treatments for depression in those with coronary disease and the findings provides valuable clinical information to help doctors determine the best treatment plan for patients. The researchers reviewed treatment trials which investigated antidepressants, psychotherapy, exercise, combined psychotherapy and antidepressants, and collaborative care (i.e. treatments devised by a multidisciplinary team of clinicians with input from the patient). To measure effectiveness, the researchers looked at factors including patient adherence to the treatment (dropout rate) and change in depressive symptoms eight weeks after commencing treatment. The strongest treatment effects were found to be exercise and combination treatments (antidepressants and psychotherapy). However, as the combination study results have a high risk of bias, the findings of the review suggest that exercise is probably the most effective treatment. Antidepressants had the most research support, while psychotherapy and collaborative care did not perform very well. "Depression is common in patients with coronary artery disease. Having both conditions can have a significant impact on the quality of life for patients so it is vital that they access to the most effective treatments," commented Dr Frank Doyle, Senior Lecturer Division of Population Health Sciences, RCSI and the study's first author. "Our study indicates that exercise is likely to be the best treatment for depression following coronary artery disease. Our findings further highlight the clinical importance of exercise as a treatment as we see that it improves not only depression, but also other important aspects of heart disease, such as lowering blood pressure and cholesterol, in these patients."  "We continue to see emerging evidence of the importance of lifestyle to treat disease - in comparison to other treatments - but further high-quality research is needed. People with coronary heart disease who have symptoms of depression should talk to their doctor about treatments that are most suitable for their personal needs, and clinicians can be confident of recommending exercise to their patients." Dr Frank Doyle and the study's senior authors, Prof. Jan Sorensen (Health Outcomes Research Centre, RCSI) and Prof. Martin Dempster (School of Psychology, Queen's University Belfast), conducted the study in collaboration with researchers in the USA, The Netherlands, the UK and Denmark. This study was also the first of its kind to establish a new method to conduct systematic reviews known as a hybrid review, which is a combination of umbrella reviews and systematic reviews.   Study examines link between obesity, food container chemical substitutes University of Iowa, June 9, 2021 A new study from the University of Iowa shows that a pair of common chemicals that manufacturers use to make plastic food containers, water bottles, and other consumer products do not contribute to obesity to the extent of the chemical it's replacing. The chemicals -- bisphenol F and bisphenol S (known as BPF and BPS) -- are being used increasingly by food packaging manufacturers as substitutes for bisphenol A (BPA), which studies have found disrupts endocrine systems and causes numerous health problems. BPA is used in many kinds of packaging for snacks and drinks, canned foods, and water bottles. The chemical is absorbed into the body mainly through the food or water it contacts in the container. But concern was raised several years ago when numerous studies found BPA increases the risk of various health issues, in particular obesity, diabetes, and cardiovascular disease. A consumer backlash erupted after the studies received media attention so manufacturers started reducing the use of BPA in some consumer products or even eliminating it in so-called "BPA-free" products by replacing it with such alternatives as BPF and BPS. However, little is known on the potential impact of BPF and BPS exposure in humans. The new University of Iowa College of Public Health study is the first to determine the health impacts of BPF and BPS exposure on obesity in humans. Using data from a nationwide population-based study conducted by the U.S. Centers for Disease Control (CDC), the researchers confirm that BPA is associated with increased obesity in humans. But the study found no links between obesity and either BPF or BPS at the current exposure levels. However, the researchers warn that fewer products currently use BPF and BPS--BPA still has more than half the global market share for the chemicals, and the average concentration of BPF and BPS is about one-fourth that of BPA in the US population. Whether BPF and BPS pose an increased risk of obesity at the same population exposure levels as BPA remains unknown. Future studies will be needed to confirm the results, as BPF and BPS are likely to replace BPA in more consumer products.

Historian Ben Baumann speaks with epidemiologist Dr. Ed Belongia about vaccines, Covid-19, and the potential for future pandemics. (Dr. Ed Belongia is the Director of the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute, an adjunct professor of Population Health Sciences at the University of Wisconsin-Madison, and former Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention. Additionally, he currently leads a research team that conducts vaccine safety and effectiveness research in collaboration with the CDC and has been interviewed and quoted by news organizations all over the United States for his work). For more on Dr. Ed Belongia visit the following links: Twitter: https://twitter.com/EdBelongia Marshfield Clinic Research Institute Profile: https://www.marshfieldresearch.org/profiles/4082 (The memories, comments, and viewpoints shared by guests in the interviews do not represent the viewpoints of, or speak for Roots of Reality)

Host: Lola Fayanju, MD, MA, MPHS In light of the upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Lola Fayanju, an Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine, shares with us some of the updates in breast cancer care amid the COVID-19 pandemic that she's most excited to learn more about at the conference.

We hear a lot about Violence Prevention Education, but what really helps? Check out the 61st Episode of the VSC Podcast featuring Education Coordinator Emilie Mitchell who chats with two incredible UCF assistant professors in the school of Social Work Dr. Julia O’Connor and Dr. Alison C. Cares about how sexual assault prevention education currently looks, what works and what doesn’t work in regards to teaching it, the possible future of prevention education, and little things we can all do every day to help end sexual assault. Dr. Alison C. Cares uses she/her pronouns and is an associate professor of sociology and member of the violence against women faculty cluster at the University of Central Florida in Orlando. Her career in the movement to end violence against women started over 20 years ago by working in community outreach in a domestic violence and sexual assault services agency. Her research often looks at campus sexual assault, including evaluation the Bringing in the Bystander in person prevention program. Dr. Julia O’Connor uses she/her pronouns and is an assistant professor at the University of Central Florida in the School of Social Work, a member of the Violence Against Women faculty cluster, and has a secondary appointment in the Department of Population Health Sciences. Julia’s practice experience includes many years as a domestic and sexual violence advocate. Her research interests include violence against women focused on primary prevention of violence, campuses, those who perpetrate violence, and marginalized populations. You can listen to this episode on our Youtube Channel: https://youtu.be/iOjC16kjh7M You can also listen to this episode on Apple Podcasts, Spotify, or wherever you get your podcasts! @Cares9505 @juliamoconno @UCF_VAW @UCFSociology ----------------------------------- Trigger Warning: In this podcast we will be discussing sensitive topics such as Sexual Assault. It's important to take care of yourself while listening. Some suggestions are listening while you're in a healthy head space or knowing who you can reach out to if you become upset. Our 24/7 helpline for crisis calls based out of Central Florida is 407 500 HEAL, for the Florida state sexual helpline call (888) 956-7273. By contacting the National Hotline at 1-800-656-4673 you can get support and learn about your local resources. There is always someone ready to help.

This week, Perpetual Notion Machine explores systemic racism. In light of Black History Month, host Anita Nsubuga discusses the effects of racism, specifically systemic racism on people of color (with emphasis on black Americans) with guest Tiffany Green. Joined by Dr. Tiffany Green, Ph.D, assistant professor from the University of Wisconsin, Population Health Sciences, they […] The post The Effect of Systemic Racism appeared first on WORT 89.9 FM.

We join Lori Merkel in a fact filled episode that takes us from a lego replica of Baby Yoda (yes, we know it's not really a baby), to her days beginning in psychology, first job as a high risk neonatal nurse and eventual job as a quality specialist. She then describes some very neat areas of nursing that are often unexplored including a job in Population Health Sciences. We explore many topics including health economics, care delivery models, health equity, implementation research and so much more. She even interviews myself at the end! Lori obtained her BA in Psychology, minor in Biology from Rutgers University then pursued her nursing degree (BSN) at Drexel University. She has obtained her Masters of Science in Public Health from Pennsylvania State University. Lori has held a certification in High Risk Neonatal Nursing and presently is a Certified Professional in Healthcare Quality. She most recently has completed her PhD at Jefferson University in Population Health Sciences with a concentration in Healthcare Quality and Safety. In her current role, she is a nurse and population health analyst in an academic primary care network as well as an adjunct professor at Jefferson University.

Thank you for joining your hosts, Adam Hunter and Corrinne Lewis, for this interview with Roger Altizer (EAE Co-Founder), Associate Professor at EAE and Population Health Sciences at the University of Utah.

Gailen Marshall, MD, PhD, FACP, FACAAI, FAAAAI, is The R. Faser Triplett Sr MD Chair of Allergy and Immunology, and a Professor of Medicine, Pediatrics, Pathology and Population Health Sciences at the University of Mississippi Medical Center. Dr. Marshall completed his medical school from University Of Texas Medical Branch at Galveston and residency from University of Iowa Roy J. and Lucille A. Carver College of Medicine. He pursued a fellowship in Allergy and Immunology from the University of Tennessee-Memphis. Dr. Marshall has published over 200 original articles, reviews, perspectives, book chapters and is a frequent keynote speaker and presenter at various international conferences. He has received many awards and honors including Gold Headed Cane Award by the American College of Allergy, Asthma and Immunology and has been featured in America's Top Doctors, Who's Who in Science and Engineering and named the Top Allergist/Immunologist by International Association of HealthCare Professionals. Modern medicine seems designed to compartmentalize patients. You have a problem with your heart. Your joints ache. You have diabetes. Each one requires specialists who focus on one part of a patient. But a patient is a whole person with a whole life and everything is interconnected. Today, Dr. Gailen Marshall shares his view of patient care by giving us an analogy, which begins with this question: “For a great symphony, which is the most important instrument?” There is no “most important instrument”. A symphony is great when all the instruments play their part in harmony. And according to Dr. Marshall, that's what the best patient-centered healthcare should do. Pearls of Wisdom: 1. We should work hard enough to say at the end of the day, “it's time to relax.” It's okay to be tired as long as you wake up the next day, still loving the work you do. 2. Try to achieve balance between humility and self-confidence: know that you know a lot, but there's more that you don't know. 3. Mentor relationships are two-way streets. For a mentee, find someone who has a genuine interest in you, have a realistic expectation of what you want, discern who you are and find a mentor who is that way. 4. The difference between a good physician and a great one is that the good one is competent; the great one is committed. A great physician doesn't compartmentalize a patient, but rather treats them as a whole.

In this episode we talk to Clare MacRae, a GP at the Centre for Population Health Sciences, Usher Institute of Population Health Sciences and Informatics in Edinburgh. Main paper: Comorbidity in chronic kidney disease:a large cross-sectional study of prevalence in Scottish primary care and this is at: https://doi.org/10.3399/bjgp20X714125 (https://doi.org/10.3399/bjgp20X714125) Additional paper discussed: Potentially inappropriate prescribing in people with chronic kidney disease: cross-sectional analysis of a large population cohort and this is at: https://doi.org/10.3399/BJGP.2020.0871 (https://doi.org/10.3399/BJGP.2020.0871) Chronic kidney disease (CKD) is common and results in significant mortality and morbidity, and is known to be commonly associated with hypertension, diabetes, and cardiovascular disease. Despite research indicating that people with CKD and comorbidity, of any type, are at increased risk of adverse clinical outcomes, little is known about the prevalence of discordant physical and mental health conditions in people with CKD. The present study found that almost all people with CKD have coexisting comorbidities, and that extreme comorbidity is >40 times more common in adults with CKD compared with age-, sex-, and deprivation-adjusted controls. The majority of discordant physical and mental health conditions were more common in people with CKD.

Today marks a significant milestone in the UK's vaccination programme as millions more people aged 70 and over are invited to receive their jabs. However, as we are making this progress, so is the virus. In this episode, we speak to UCL experts from the Department of Primary Care & Population Health and the Faculty of Population Health Sciences to find out more about how the vaccine roll-out works, and whether it will work on the new variant of the virus.Special guests:- Prof Martin Marshall- Prof Deenan Pillay- Prof Helen BedfordMore info: www.ucl.ac.uk/ucl-minds/coronavirusTranscript: www.ucl.ac.uk/ucl-minds/podcasts/coronavirus/transcript-episode-35If you've got a question about the pandemic you'd like UCL researchers to answer, please get in touch by emailing UCL's Communications and Marketing team on minds@ucl.ac.uk – we'd love to hear from you. See acast.com/privacy for privacy and opt-out information.

Today marks a significant milestone in the UK’s vaccination programme as millions more people aged 70 and over are invited to receive their jabs. However, as we are making this progress, so is the virus. In this episode, we speak to UCL experts from the Department of Primary Care & Population Health and the Faculty of Population Health Sciences to find out more about how the vaccine roll-out works, and whether it will work on the new variant of the virus. Special guests: - Prof Martin Marshall - Prof Deenan Pillay - Prof Helen Bedford More info: www.ucl.ac.uk/ucl-minds/coronavirus Transcript: https://www.ucl.ac.uk/ucl-minds/podcasts/coronavirus/transcript-episode-35 If you’ve got a question about the pandemic you’d like UCL researchers to answer, please get in touch by emailing UCL’s Communications and Marketing team on minds@ucl.ac.uk – we’d love to hear from you.

In this episode we talk to Daniela Strelchuk from Population Health Sciences at the University of Bristol and Professor Stan Zammit from the Centre for Academic Mental Health, also at Bristol. The paper is: Identifying patients at risk of psychosis: a qualitative study of GP views in South West England Read the paper: https://doi.org/10.3399/bjgp20X713969 (https://doi.org/10.3399/bjgp20X713969) Previous research has shown that GPs have limited knowledge about the insidious symptoms of psychosis but little is known about the difficulties that GPs face in identifying patients at risk of psychosis. This study used semi-structured interviews to explore GPs' experiences of this patient group, and found that some GPs were not familiar with the concept of being at risk of developing psychosis. Whereas this could, in itself, be a barrier to identifying these patients, other barriers were present that related to patients not consulting or disclosing psychotic symptoms, lack of continuity of care, and high thresholds for accessing secondary care services.

Kevin Weinfurt, PhD, is the vice chair for research in the Department of Population Health Sciences at Duke University School of Medicine. His work measures sexual function and satisfaction and how sexual well-being can be impacted by illness and other changes in health throughout our lives. Weinfurt talks about why he believes doctors tend to avoid the subject of sex and how he and his colleagues hope to change this. He also talks about the role that intimacy plays in sexual wellness—i.e., holding hands, making eye contact, and simply touching. And he explains some of the psychology around our relationship to our sex lives, like why sex can be so important to some people but not to others. (For more, see The goop Podcast hub.) Learn more about your ad choices. Visit podcastchoices.com/adchoices

Qatar, a great field experiment in understanding factors affecting COVID incidence rates, mortality, herd immunity, testing, reinfection, and vaccination and forming policies for the future. Laith Abu-Raddad is a Professor of Population Health Sciences at Cornell University in Qatar. He is also the director of the WHO Collaborating Center for Disease Analytics on HIV, Sexually Transmitted Infections, and Viral Hepatitis. Previously he held academic and research positions at the University of Washington, Imperial College London, and Osaka University. --- Send in a voice message: https://anchor.fm/scientificsense/message Support this podcast: https://anchor.fm/scientificsense/support

In The Straits Times The Big Story, ST’s multimedia correspondent Hairianto Diman and multimedia journalist Dylan Ang spoke to Associate Professor Josip Car, director of the Centre for Population Health Sciences at Nanyang Technological University's Lee Kong Chian School of Medicine, on why it is a good time to allow the easing of workplace restrictions and the possible pitfalls to look out for as Covid-19 restrictions ease. See omnystudio.com/listener for privacy information.

The recent murder of George Floyd, among others, has once again brought to the forefront discourse on the deep-rooted, structural obstacles and mistreatment that black people face. Those roots have grown into our own profession as well, so join the BTK team this week as we discuss the serious topic of systemic racism in surgery and how we can begin to overcome it. Featuring our guests: Carla Pugh, MD, PhD; Professor of Surgery at Stanford University, Acute Care Surgeon, Director of the Technology Enabled Clinical Improvement Center Lola Fayanju, MD, MA; Assistant Professor of Surgery and Population Health Sciences at Duke University, Associate Director for Disparities & Value in Healthcare with Duke Forge Fabian Johnston, MD, MHS; Associate Professor of Surgical Oncology, Chief of GI Surgical Oncology, Director of the Peritoneal Surface Malignancy Program, Program Director of the Complex General Surgery Oncology Fellowship at Johns Hopskins University

In this episode, we're discussing the integration of population health, prevention, health promotion and wellness activities into clinical practice. With decades of research supporting the benefits of lifestyle changes on positive health outcomes, physical therapists and other health professionals are exploring and weaving integrative and lifestyle medicine into both insurance and cash-based practice settings, as well as community health and serving the private sector business. Lifestyle changes, including physical activity, nutrition and stress management all lead to improved health benefits in those with chronic disease and prevent or manage a number of non-communicable diseases, which lead to an increased quality of life. Physical therapists are well-positioned to treat non-communicable diseases through the integration of population health, prevention, health promotion, and wellness activities into clinical practice. Joining us to discuss the topics of health promotion prevention, wellness in physical therapy practice is Professor Dawn Magnusson. She is an Assistant Professor in Physical Therapy at The University of Colorado. She received a Master's degree in Physical Therapy and then went on to pursue a PhD in Population Health Sciences. Her research employs community-based methods within a population health framework and informs the development of innovative community-based solutions to advance health equity for underserved children. In this episode, you'll learn all about population health, why physical therapists should care about population health, what the integration of population health and physical therapist practice looks like, how disease prevention, health promotion fit into population health and how physical therapists can become more active in population health, disease prevention, as well as health promotion. This is a big and important topic that has implications both for the entry-level of physical therapy education as well as clinical practice. Let's get ready and let's begin with Professor Dawn Magnusson.

Host: John Bowser, St. Ambrose University Adjunct Professor, PhD, Population Health Sciences, MS, Human and Community ResourcesAbout: www.sau.edu/john-bowserGuest: Colleen Doak, St. Ambrose University Associate Professor, PhD, Public Health, Nutrition, and Epidemiology, MS, AnthropologyAbout: www.sau.edu/colleen-doakGuest: Melissa Sharer, St. Ambrose University Master of Public Health Program Director, Assistant Professor, PhD, MSW, MPHAbout: www.sau.edu/melissa-sharerConnect with us!Email: ipcc@sau.eduFacebook: facebook.com/SAUIPCC/Twitter: @sau_ipccOfficial Health Sources:CDC - www.cdc.gov/WHO - www.who.int/Rock Island Co. Health Dept. - richd.org/Scott Co. Health Dept. - www.scottcountyiowa.com/healthIllinois Dept. of Public Health - www.dph.illinois.gov/Iowa Dept. of Public Health - idph.iowa.gov/Quad Cities COVID-19 Coalition - togetherqc.com**THIS PODCAST WAS RECORDED THROUGH THE PHONE FOR THE HEALTH AND SAFETY OF ALL PARTICIPANTS AND TO FOLLOW CURRENT RECOMMENDED HEALTH GUIDELINES.**St. Ambrose University is located in Davenport, Iowa, USA.

Taryn Vian (@TarynVian), Prof. at the Department of Population Health Sciences, School of Nursing and Health Professions, University of San Francisco (USF). For people who think about the relationship between corruption & public health, what are some of the main lines of research & what are some of the important findings? Taryn outlines that one main problem lies in the fact that people have to pay doctors for public health services that are supposed to be free of charge. Quantitative & qualitative studies have investigated why people pay doctors & how they know why they have to pay or give “gifts” while intervention has tested how corrupt practices like informal payments & absenteeism can be reduced. What does health care corruption- look like during times of emergencies in comparison to “normal times”? Taryn points out that one of the risk factors for corruption during emergencies stems from the pressure to finish things quickly. Such pressures can create incentives to ignore controls. As a result, higher tolerance of saying “we’ll figure out the paperwork later” often emerges. In an emergency situation is it even more important that we stick to corruption guidelines or not? How do you implement the right measures in emergency situations? Taryn describes audits conducted by the catholic relief service after a natural disaster revealing 100 findings. Yet, closer examination often revealed that minimal mistakes were committed such as a single missing signature out of four. This suggests that we need to find a different procedure for times of emergency. There are streamlined processes e.g. for the procurement of emergency medicine. How many countries in the world have implemented emergency measures/procedures? Are there examples? There were gaps in procurements of test kits in the US because the US proceeded as business as usual. Many countries have emergency procurement procedures. The question is how to launch such special procedures at the right time for the right products & also still holding people accountable. What observations do you have on a relation between the coronavirus pandemic & corruption? One place where Taryn sees a link between corruption & the Coronavirus play out is in the US. Here, one of the big problems is that the government has not appointed actors, which undermines the trust between decision-makers & scientific leaders. There is a lack of trust in science in our government right now. The personalization of power is a big problem. Such distrust can have very adverse effects. In a public health crisis, the government needs to give directives to people. Directives that are not popular. If there is no trust in the government, people will not want to follow their directives. Yes, e.g. Ebola crisis in Sierra Leone & Liberia. People were actively avoiding government directives because there was no trust. Corruption during “normal” times eroded the trust towards the government bodies which undermines emergency response efforts as people might to not comply with the recommendations or orders of the government. Informal payments & bribes during normal times do have an adversarial effect on trust in the payment system. Can you elaborate on the evidence for this claim? Dagmar Radin looked at the connection between corruption & trust. She argued that there is a connection. Other work showing similar links stems from Nicaragua, where a comparison of social audits over a 4 year period has been conducted, showing that trust increased when the government tried to work against informal payments. Which measures have been effective in reducing corruption in the health sector under control? There is a famous study on community monitoring in Uganda by the World Bank showing promising effects of involving communities to increase accountability. However, studies by the Harvard Kennedy School in Tanzania did not exactly replicate the findings above. There have been many interventions against corruption.

Host: John Bowser, St. Ambrose University Adjunct Prof., PhD, Population Health Sciences, MS, Human and Community Resources - About: https://www.sau.edu/john-bowserGuest: Natalie Truesdell, Consultant for John Snow, Inc., a public health management consulting and research organization - About: https://www.njpca.org/dvteam/natalie-truesdell-mba-mph/Connect with us!Email: ipcc@sau.eduFacebook: facebook.com/SAUIPCC/Twitter: @sau_ipccOfficial Health Sources: CDC - https://www.cdc.gov/WHO - https://www.who.int/Rock Island Co. Health Dept. - https://richd.org/Scott Co. Health Dept. - https://www.scottcountyiowa.com/healthIllinois Dept. of Public Health - http://www.dph.illinois.gov/Iowa Dept. of Public Health - https://idph.iowa.gov/**THIS PODCAST WAS RECORDED THROUGH THE PHONE FOR THE HEALTH AND SAFETY OF ALL PARTICIPANTS AND TO FOLLOW CURRENT RECOMMENDED HEALTH GUIDELINES.** St. Ambrose University is located in Davenport, Iowa, USA.

This episode explores genetic risk factors for early- and late-onset Alzheimer’s disease. Host Nathaniel Chin and guest Corinne Engelman discuss the research looking into genetic risk for Alzheimer’s disease and the uncertainty that comes with genetic testing. Guest: Corinne Engelman, MSHP, PhD, associate professor, Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health Episode Topics: What are the genetic influences on a person’s risk for Alzheimer’s disease? 2:07 What genes affect individuals with early-onset dementia? 2:56 What is the impact of genes that counter one another? 5:34 How much can our lifestyle choices affect our genetic risk? 7:52 How is the genetic testing being analyzed? 9:03  What can at-home genetic testing tell us about Alzheimer’s disease? 10:06 How essential is the role of genetic counselor? 11:47 Have we found any genetic risks related to the aging process? 13:21 What advice do you have for people interested in maximizing their genetic outcome when it comes to Alzheimer's disease risk? 14:40 

Can nutrition education solve the obesity epidemic? Hannah Cory asked that question over and over while working as a dietician in a public school system. Now, as a PhD candidate in Population Health Sciences, Hannah’s research seeks to uncover the connection between fat-phobia, racism, and obesity in the US. Full Transcript The Veritalk Team: Host/Producer: Anna Fisher-Pinkert Sound Designer: Ian Coss Logo: Emily Crowell Executive Producer: Ann Hall Special Thanks: Hannah Cory, Rick Sheiber, Julia King, Noah Leavitt, and the PRX Podcast Garage.

Dr. Josée Lavoie explains how Canadian health care works, and where improvements could be made to better meet the healthcare needs of all Canadians. (Note, the presentation that accompanies the audio podcast is also posted in iTunes.) The Canada Health Act 1984 (CHA) is considered foundational to Canada’s publicly funded health care system (known as Medicare). The CHA provides for the federal transfer of funding to the provinces/territories, in exchange for provincial/territorial adherence to Medicare’s key principles of universality, comprehensiveness, portability, accessibility, and public administration. Medicare is a decentralized health care system, managed independently by Canada’s 10 provincial and three territorial governments, allowing for regional adaptations to fit varying degrees of urbanity, remoteness and needs. The Act extends care to Indigenous Canadians (First Nations, Métis and Inuit). The Act is however silent on its relationship to the Indigenous health care system – what some have described as Canada’s 14th health care system. The CHA has not kept pace with Indigenous self-government activities that have since spread across Canada. It has unfortunately crystallized the federal/provincial/territorial/Indigenous jurisdictional fragmentation that perpetuates health inequities and has failed to clarify these jurisdictions’ obligations towards Indigenous peoples. Dr.Josée Lavoie is of French Quebec ancestry, raised in northern Quebec isolated communities. She is a Professor in the Department of Community Health Sciences at the University of Manitoba, Canada and Director of Ongomiizwin Research. A Fulbright Arctic Scholar from 2018-19, she holds a PhD in Health Policy and Financing from the London School of Hygiene and Tropical Medicine, UK. This event is sponsored with the UAA Division of Population Health Sciences, Master of Public Health Program.

Dr. Jeffrey Jim is an Associate Professor of Surgery and Program Director, Vascular Surgery Fellowship and Integrated Residency at the Barnes-Jewish Hospital and Washington University in St Louis, Missouri. He takes some time to discuss the basics of TransCarotid Artery Revascularization (TCAR), comparative effectiveness research and drivers of cost in vascular surgery. Disclosures: Consultant for Silk Road Medical (Proctor, Co-Director of National Test Drive: Education courses for physicians) Consultant for Medtronic (speaker/educational content) (0:28) Academic Bio and Video Bio (4:22) TransCarotid Artery Revascularization (14:22) Updated data and publications on TCAR 1-year outcomes of ROADSTER trial Multi-Institution data observational data SVS-VQI Registry data (19:45) Long term outcomes of carotid stenting (22:00) Masters in Population Health Sciences (23:10) Cost-effectiveness analyses in Vascular Surgery (29:30) Predicting future workload and implications for training and SVS comments on vascular surgery workforce

Our guest today is XinQi Dong, director of Rutgers University’s Institute for Health, Health Care Policy, and Aging Research, or IFH. In addition to the institute directorship, he serves as the inaugural Henry Rutgers Professor of Population Health Sciences. He is the lead researcher of the Population Study of Chinese Elderly in Chicago, which examined the health and well being of Chinese older adults and culminated in the publishing of 20 articles, which is the topic of today’s podcast. Most recently, XinQi was a professor of Medicine, Nursing, and Behavioral Sciences at the Rush University Medical Center and the associate director of the Rush Institute for Healthy Aging.

In today’s podcast, we’ll talk with XinQi Dong, Director of Rutgers University’s Institute for Health, Health Care Policy, and Aging Research. In addition to the institute directorship, Dong will serve as the inaugural Henry Rutgers Professor of Population Health Sciences. Most recently, he was a Professor of Medicine, Nursing, and Behavioral Sciences at the Rush University Medical Center and the Associate Director of the Rush Institute for Healthy Aging. His research and advocacy have been recognized by many national and international organizations, including awards by the American Public Health Association, American Geriatric Society, Gerontological Society of America, and International Congress of Gerontology and Geriatrics. He was the first geriatrician to receive the National Physician Advocacy Merit Award by the Institute on Medicine as a Profession. This year, he was elected to the prestigious American Society of Clinical Investigation. He has served as a commissioner for the Commission on Law and Aging at the American Bar Association, and he chaired the workshop on elder abuse prevention for the Institute of Medicine’s Global Violence Prevention Forum. A native of China, he completed his geriatric fellowship at Yale University Medical Center.

Dr. Dawn Magnusson of the APHPT and University of Colorado Anschutz Medical Campus comes on the show today to discuss her academic journey,Population Health Sciences, the layers of Wellness and Disease Prevention, wellness and prevention in regards to population health, and possible business models around prevention and wellness APHPT Website: https://www.aphpt.org/ APTA Council on Prevention, Health Promotion, and Wellness: http://www.apta.org/PHPW/ CU Anshutz: http://www.ucdenver.edu/anschutz/Pages/landing.aspx Dawn's Twitter Page: www.twitter.com/DawnMagnusson Dawn's Facebook Page: https://www.facebook.com/profile.php?id=816178728 Dawn's Instagram Page: www.instagram.com/madison31 APHPT Twitter Page: https://twitter.com/TheAPHPT APHPT Instagram Page: https://www.instagram.com/theaphpt/ Dawn Magnusson Bio: Dawn is an Assistant Professor in the Physical Therapy Program at the University of Colorado Anschutz Medical Campus. She received her PhD in Population Health Sciences (with a minor in Anthropology), a certificate in Global Health, and an MS in Physical Therapy from the University of Wisconsin – Madison, and completed a postdoctoral fellowship in General Academic Pediatrics (with a focus on health disparities research) through the Department of Pediatrics at the Johns Hopkins School of Medicine. Her research broadly explores the mechanisms underlying health disparities in vulnerable populations, and seeks to inform the development of innovative, community-based models of care that advance health equity for traditionally underserved populations of children with developmental delay or disability. With regard to entry-level DPT education, Dr. Magnusson is responsible for teaching CU's health and wellness content, and provides population health content throughout the curriculum. In recognition of her research and dedication in the area of health equity, Dr. Magnusson received a 2013 Wisconsin without Borders Award from the University of Wisconsin – Madison, the 2015 Dissertation Award from the Academy of Pediatric Physical Therapy, and the 2016 Social Responsibility Research Award from the HPA-The Catalyst Section of the APTA. She was also named a 2016 semi-finalist for the Robert Wood Johnson Foundation's Culture of Health Leaders Program.      

The United States infant mortality rate ranks among the worst for wealthy nations, a clear sign that our nation’s health needs improving. This year’s Frontiers in Precision Medicine III symposium will focus on combining the best approaches from two seemingly disparate disciplines—population health and individualized medicine—to pave the way toward a brighter future. Symposium organizer and assistant professor of Population Health Sciences Adam Bress, Pharm D, explains controversies that will be addressed in dynamic and interactive panel-based discussions led by national experts in the fields of health disparities, big data, direct-to-consumer genetic testing, and more. The symposium will be held on March 16, 2018 on the University of Utah campus. Registration is free, and CME credits are available.

Population health is a new way of approaching health care that emphasizes prevention in a population rather than treatment of an individual. Angie Fagerlin, chair of the Department of Population Health Sciences at University of Utah Health, explains how a population-focused approach could improve overall health and reduce the cost of care.

The Seventeenth Population Health Colloquium organized by the Jefferson College of Population Health convened in Philadelphia, PA from March 27-29, 2017 at the Loews Philadelphia Hotel. David Nash, MD, MBA Dean of the Jefferson College of Population Health served as master of ceremonies presiding over 2 1/2 days of power packed presentations by key thought leaders in population health sciences. In today's uncertain and volatile climate, the practice of population health has taken on even more importance. As health care leaders, we understand the impact of social determinants on our nation's health. The fact that zip code is a better predictor of health than a person's genetic code is a clear indicator of the need to create healthier communities. In this interview we chat with Joseph F. Coughlin, Ph.D., is founder and Director of the Massachusetts Institute of Technology AgeLab. He teaches in MIT's Department of Urban Studies & Planning and the Sloan School’s Advanced Management Program. His research focuses on how demographic change, technology, social trends and consumer behavior drive innovations in business and government. Enjoy!  

Listen NowIn mid-January the CDC abruptly canceled a three-day "Climate and Health Summit" the Center had been planning for months.  The meeting was intended to discuss public health risks caused by the climate crisis and steps being taken to reduce the emissions of carbon dioxide and other greenhouse gases or its adverse consequences on human health.   (It was speculated the meeting was canceled because the CDC did not want to run afoul of the incoming president who has repeatedly called climate change a “hoax” perpetrated by the Chinese.)   The American Public Health Association (APHA) and others however went ahead and held a one-day meeting on February 16 titled,"Climate and Health" at the Carter Center in Atlanta.  The meeting was keynoted by former Vice President Al Gore.   Dr. Jonathan Patz, the Director of the Global Health Institute at the University of Wisconsin-Madison, was one of the meeting's organizers and participants.    During this 24 minute conversation Dr. Patz discusses how the meeting came about and what was accomplished, e.g., he summarizes the afternoon's panels that discussed what's being done to reduce green house gas emissions.  He also discussed how to better involve the professional medical community  and how to effectively communicate the reality of the climate crisis. Dr. Jonathan Patz is the Director of the Global Health Institute at the University of Wisconsin-Madison.  He is a professor and the John P. Holton Chair in Health and the Environment with appointments in the Nelson Institute for Environmental Studies and the Department of Population Health Sciences.  For 15 years, Dr. Patz served as a lead author for the United Nations Intergovernmental Panel on Climate Change (or IPCC)—the organization that shared the 2007 Nobel Peace Prize with Al Gore.  He also co-­chaired the health expert panel of the U.S. National Assessment on Climate Change, a report mandated by the Congress.  Dr. Patz has written over 90 peer-reviewed articles, a textbook addressing the health  the health effects of global environmental change and co-edited the five volume Encyclopedia of Environmental Health (2011).  He has been invited to brief both houses of Congress and has served on several scientific committees of the National Academy of Sciences.  Dr. Patz served as Founding President of the International Association for Ecology and Health.  He is double board-­certified, earning medical boards in both Occupational/Environmental Medicine and Family Medicine.  He received his medical degree from Case Western Reserve University (1987) and his Master of Public Health degree (1992) from Johns Hopkins University.A webcast of the February 16 meeting is at: https://www.climaterealityproject.org/health.  Listeners are particularly encouraged to listen to Vice President Gore's 30 minute keynote address.  For more information concerning the Medical Society Consortium on Climate and Health go to: https://medsocietiesforclimatehealth.org/.Since I mention during the discussion the Obama administration's 2016 "The Impacts of Climate Change on Human Health in the US: A Scientific Assessment," a review of the paper is, again, at: http://altarum.org/health-policy-blog/nature-bats-last-a-warming-earth-will-exact-adverse-health-effects-but-our-responsibilities-are.    This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

Honeybees, among all types of pollinators, pollinate over 1/3 of all U.S. foodstuffs. And they are in trouble. Colony Collapse Disorder is just one of a hive of serious issues compromising the health of honeybees kept by commercial-scale and hobby beekeepers, here and abroad. Many stakeholders share concerns - and conflicting views - about honeybee health: agricultural growers, government agencies, pesticide and herbicide manufacturing corporations, scientists, academics and - of course - beekeepers at every honeybee husbandry scale. Why can't these interests concur about causes - and work toward solutions - to critical bee-health issues?                 Researchers from the University of Wisconsin explored what is "credible" and "trusted" amid the human buzz of bee-related viewpoints, while also digging into bee health issue details. Biologist Dr. Sainath Suryanarayanan talks with Earthworms host jean Ponzi about this work. He co-authored the new book "Vanishing Bees: Science, Politics, and Honeybee Health" (Rutgers University Press, 2016) with sociologist Dr. Daniel Lee Kleinman. Suryanarayan is Associate Scientist for the Study of Trans-Disciplinary Biomedical Research, Department of Population Health Sciences, UW-Madison. MUSIC: Abdiel, performed live at KDHX by Dave Black, January 2011 THANKS to Josh Nothum, Earthworms engineer, and to Peter Bermudes of Gail Leondar Public Relations. MORE ABOUT BEES from Eastern Missouri Beekeepers coming in the January 24 Earthworms podcast.   

What is going on inside Britain's families? From three-parent families and surrogacy, to stepfamilies - the fastest rising type of home in the UK - the days of the 'traditional' family are apparently over. The divorce rate in the UK stands at 42%, the highest in the EU, yet nearly 75% of us apparently consider ourselves to be happy with our lives at home. So what are the new rules of family life?Joining Free Thinking presenter Anne McElvoy are:Anne Fine - the first Children's Laureate and an acclaimed author of books for adults and children including Madame Doubtfire and Telling Liddy.Tobias Jones - a novelist and communalist who opened his home as a sanctuary for people in a period of crisis and explores the results in his new book, A Place of Refuge: an Experiment in Communal Living.Professor Sarah Cunningham-Burley, Professor of Medical and Family Sociology, Centre for Population Health Sciences and founding co-director, Centre for Research on Families and Relationships, University of Edinburgh.Dr Tom Shakespeare from the University of East Anglia researches disability studies, medical sociology and ethical aspects of genetics.Recorded in front of an audience during the Free Thinking Festival at Sage Gateshead.Producer: Luke Mulhall